Summary
Structures and Sequence Alignment
The best structural homolog that predicted by 1. PB was
P01256
(Calcitonin gene-related peptide 1) with a FATCAT P-Value: 4.11e-10 and RMSD of 1.80 angstrom. The sequence alignment identity is 79.1%.
Structural alignment shown in left. Query protein P06881 colored as red in alignment, homolog P01256 colored as blue.
Query protein P06881 is also shown in right top, homolog P01256 showed in right bottom. They are colored based on secondary structures.
P06881 MGFQKFSPFLALSILVLLQA-GSLHAAPFRSALESSPADPATLSEDEARLLLAALVQDYVQMKASELEQEQEREGSRIIAQKRACDTATCVTHRLAGLLS 99 P01256 MGFLKFSPFLVVSILLLYQACG-LQAVPLRSTLESSPGMAATLSEEEARLLLAALVQNYMQMKVRELEQEQEAEGSSVTAQKRSCNTATCVTHRLAGLLS 99 P06881 RSGGVVKNNFVPTNVGSKAFGRRRRDLQA 128 P01256 RSGGVVKDNFVPTNVGSEAFGRRRRDLQA 128
Go Annotations
1. PB indicates the go terms that are found by both PROST and BLAST.2. P indicates the go terms that are found by only PROST.
3. B indicates the go terms that are only annotated by BLAST.
Source | GO | Description |
---|---|---|
1. PB | GO:0006954 | inflammatory response |
1. PB | GO:0009408 | response to heat |
1. PB | GO:0007267 | cell-cell signaling |
1. PB | GO:0043005 | neuron projection |
1. PB | GO:0002548 | monocyte chemotaxis |
1. PB | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway |
1. PB | GO:0001878 | response to yeast |
1. PB | GO:0001976 | nervous system process involved in regulation of systemic arterial blood pressure |
1. PB | GO:0097647 | amylin receptor signaling pathway |
1. PB | GO:0051480 | regulation of cytosolic calcium ion concentration |
1. PB | GO:0005102 | signaling receptor binding |
1. PB | GO:0030279 | negative regulation of ossification |
1. PB | GO:0007204 | positive regulation of cytosolic calcium ion concentration |
1. PB | GO:0001984 | artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure |
1. PB | GO:0045776 | negative regulation of blood pressure |
1. PB | GO:0019233 | sensory perception of pain |
1. PB | GO:0050965 | detection of temperature stimulus involved in sensory perception of pain |
1. PB | GO:0030424 | axon |
1. PB | GO:0005184 | neuropeptide hormone activity |
1. PB | GO:0043025 | neuronal cell body |
1. PB | GO:0045671 | negative regulation of osteoclast differentiation |
1. PB | GO:1990090 | cellular response to nerve growth factor stimulus |
1. PB | GO:0007218 | neuropeptide signaling pathway |
1. PB | GO:0007566 | embryo implantation |
1. PB | GO:0007631 | feeding behavior |
1. PB | GO:0005179 | hormone activity |
1. PB | GO:0042755 | eating behavior |
1. PB | GO:0045986 | negative regulation of smooth muscle contraction |
1. PB | GO:0031716 | calcitonin receptor binding |
1. PB | GO:0006874 | cellular calcium ion homeostasis |
1. PB | GO:0005576 | extracellular region |
1. PB | GO:0007190 | activation of adenylate cyclase activity |
1. PB | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
1. PB | GO:0043195 | terminal bouton |
1. PB | GO:0007568 | aging |
1. PB | GO:0008016 | regulation of heart contraction |
1. PB | GO:0042311 | vasodilation |
1. PB | GO:0045779 | negative regulation of bone resorption |
1. PB | GO:0005615 | extracellular space |
1. PB | GO:0048265 | response to pain |
1. PB | GO:0045785 | positive regulation of cell adhesion |
1. PB | GO:0019732 | antifungal humoral response |
2. P | GO:0007617 | mating behavior |
2. P | GO:0031652 | positive regulation of heat generation |
2. P | GO:0060621 | negative regulation of cholesterol import |
2. P | GO:0048046 | apoplast |
2. P | GO:1905333 | regulation of gastric motility |
2. P | GO:0050729 | positive regulation of inflammatory response |
2. P | GO:0051216 | cartilage development |
2. P | GO:0120020 | cholesterol transfer activity |
2. P | GO:0008283 | cell population proliferation |
2. P | GO:0006641 | triglyceride metabolic process |
2. P | GO:0010900 | negative regulation of phosphatidylcholine catabolic process |
2. P | GO:0043011 | myeloid dendritic cell differentiation |
2. P | GO:1904055 | negative regulation of cholangiocyte proliferation |
2. P | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion |
2. P | GO:0007205 | protein kinase C-activating G protein-coupled receptor signaling pathway |
2. P | GO:0005183 | gonadotropin hormone-releasing hormone activity |
2. P | GO:0090312 | positive regulation of protein deacetylation |
2. P | GO:0060192 | negative regulation of lipase activity |
2. P | GO:0050995 | negative regulation of lipid catabolic process |
2. P | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
2. P | GO:0030334 | regulation of cell migration |
2. P | GO:0032097 | positive regulation of response to food |
2. P | GO:0019731 | antibacterial humoral response |
2. P | GO:0008289 | lipid binding |
2. P | GO:0031704 | apelin receptor binding |
2. P | GO:0006959 | humoral immune response |
2. P | GO:0042127 | regulation of cell population proliferation |
2. P | GO:0097191 | extrinsic apoptotic signaling pathway |
2. P | GO:0071866 | negative regulation of apoptotic process in bone marrow cell |
2. P | GO:0030301 | cholesterol transport |
2. P | GO:0050769 | positive regulation of neurogenesis |
2. P | GO:0005133 | interferon-gamma receptor binding |
2. P | GO:0010753 | positive regulation of cGMP-mediated signaling |
2. P | GO:0016239 | positive regulation of macroautophagy |
2. P | GO:0002719 | negative regulation of cytokine production involved in immune response |
2. P | GO:0046676 | negative regulation of insulin secretion |
2. P | GO:1903816 | positive regulation of collecting lymphatic vessel constriction |
2. P | GO:1903766 | positive regulation of potassium ion export across plasma membrane |
2. P | GO:0030354 | melanin-concentrating hormone activity |
2. P | GO:0030300 | regulation of intestinal cholesterol absorption |
2. P | GO:0010460 | positive regulation of heart rate |
2. P | GO:0005136 | interleukin-4 receptor binding |
2. P | GO:0008217 | regulation of blood pressure |
2. P | GO:0030223 | neutrophil differentiation |
2. P | GO:0007586 | digestion |
2. P | GO:1902261 | positive regulation of delayed rectifier potassium channel activity |
2. P | GO:2000253 | positive regulation of feeding behavior |
2. P | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep |
2. P | GO:0042157 | lipoprotein metabolic process |
2. P | GO:2000987 | positive regulation of behavioral fear response |
2. P | GO:0008542 | visual learning |
2. P | GO:0009395 | phospholipid catabolic process |
2. P | GO:0060333 | interferon-gamma-mediated signaling pathway |
2. P | GO:0071677 | positive regulation of mononuclear cell migration |
2. P | GO:0060348 | bone development |
2. P | GO:0035792 | host cell postsynaptic membrane |
2. P | GO:0120061 | negative regulation of gastric emptying |
2. P | GO:0071855 | neuropeptide receptor binding |
2. P | GO:0060695 | negative regulation of cholesterol transporter activity |
2. P | GO:0048261 | negative regulation of receptor-mediated endocytosis |
2. P | GO:0061049 | cell growth involved in cardiac muscle cell development |
2. P | GO:1900100 | positive regulation of plasma cell differentiation |
2. P | GO:0031766 | type 3 galanin receptor binding |
2. P | GO:1904022 | positive regulation of G protein-coupled receptor internalization |
2. P | GO:0043627 | response to estrogen |
2. P | GO:0006656 | phosphatidylcholine biosynthetic process |
2. P | GO:0033574 | response to testosterone |
2. P | GO:0090548 | response to nitrate starvation |
2. P | GO:0032100 | positive regulation of appetite |
2. P | GO:0030296 | protein tyrosine kinase activator activity |
2. P | GO:0090398 | cellular senescence |
2. P | GO:0042307 | positive regulation of protein import into nucleus |
2. P | GO:0002903 | negative regulation of B cell apoptotic process |
2. P | GO:0031210 | phosphatidylcholine binding |
2. P | GO:0031763 | galanin receptor binding |
2. P | GO:0090324 | negative regulation of oxidative phosphorylation |
2. P | GO:0034369 | plasma lipoprotein particle remodeling |
2. P | GO:0034380 | high-density lipoprotein particle assembly |
2. P | GO:0032700 | negative regulation of interleukin-17 production |
2. P | GO:0005134 | interleukin-2 receptor binding |
2. P | GO:0051428 | peptide hormone receptor binding |
2. P | GO:0045987 | positive regulation of smooth muscle contraction |
2. P | GO:0002677 | negative regulation of chronic inflammatory response |
2. P | GO:1901371 | regulation of leaf morphogenesis |
2. P | GO:0032735 | positive regulation of interleukin-12 production |
2. P | GO:0060557 | positive regulation of vitamin D biosynthetic process |
2. P | GO:0005634 | nucleus |
2. P | GO:0031012 | extracellular matrix |
2. P | GO:0072651 | interferon-tau production |
2. P | GO:1900158 | negative regulation of bone mineralization involved in bone maturation |
2. P | GO:0097746 | blood vessel diameter maintenance |
2. P | GO:0034695 | response to prostaglandin E |
2. P | GO:0010629 | negative regulation of gene expression |
2. P | GO:0043203 | axon hillock |
2. P | GO:0003418 | growth plate cartilage chondrocyte differentiation |
2. P | GO:0016042 | lipid catabolic process |
2. P | GO:0010987 | negative regulation of high-density lipoprotein particle clearance |
2. P | GO:0001764 | neuron migration |
2. P | GO:0014898 | cardiac muscle hypertrophy in response to stress |
2. P | GO:0042632 | cholesterol homeostasis |
2. P | GO:0044849 | estrous cycle |
2. P | GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance |
2. P | GO:0031877 | somatostatin receptor binding |
2. P | GO:0042976 | activation of Janus kinase activity |
2. P | GO:1902948 | negative regulation of tau-protein kinase activity |
2. P | GO:0032736 | positive regulation of interleukin-13 production |
2. P | GO:0035177 | larval foraging behavior |
2. P | GO:0042493 | |
2. P | GO:0014049 | positive regulation of glutamate secretion |
2. P | GO:0010835 | regulation of protein ADP-ribosylation |
2. P | GO:0098556 | cytoplasmic side of rough endoplasmic reticulum membrane |
2. P | GO:0019933 | cAMP-mediated signaling |
2. P | GO:1904179 | positive regulation of adipose tissue development |
2. P | GO:0034375 | high-density lipoprotein particle remodeling |
2. P | GO:0051965 | positive regulation of synapse assembly |
2. P | GO:0032747 | positive regulation of interleukin-23 production |
2. P | GO:0035814 | negative regulation of renal sodium excretion |
2. P | GO:0060559 | positive regulation of calcidiol 1-monooxygenase activity |
2. P | GO:0032691 | negative regulation of interleukin-1 beta production |
2. P | GO:0042629 | mast cell granule |
2. P | GO:0030133 | transport vesicle |
2. P | GO:0060259 | regulation of feeding behavior |
2. P | GO:0045944 | positive regulation of transcription by RNA polymerase II |
2. P | GO:0045725 | positive regulation of glycogen biosynthetic process |
2. P | GO:0050830 | defense response to Gram-positive bacterium |
2. P | GO:1903672 | positive regulation of sprouting angiogenesis |
2. P | GO:0040013 | negative regulation of locomotion |
2. P | GO:0030252 | growth hormone secretion |
2. P | GO:0060183 | apelin receptor signaling pathway |
2. P | GO:0033700 | phospholipid efflux |
2. P | GO:0048873 | homeostasis of number of cells within a tissue |
2. P | GO:0045475 | locomotor rhythm |
2. P | GO:0060732 | positive regulation of inositol phosphate biosynthetic process |
2. P | GO:0001774 | microglial cell activation |
2. P | GO:0005126 | cytokine receptor binding |
2. P | GO:0060552 | positive regulation of fructose 1,6-bisphosphate metabolic process |
2. P | GO:0034362 | low-density lipoprotein particle |
2. P | GO:0046887 | positive regulation of hormone secretion |
2. P | GO:0045168 | cell-cell signaling involved in cell fate commitment |
2. P | GO:1990637 | response to prolactin |
2. P | GO:0031530 | gonadotropin-releasing hormone receptor binding |
2. P | GO:0007409 | axonogenesis |
2. P | GO:0005129 | granulocyte macrophage colony-stimulating factor receptor binding |
2. P | GO:0005543 | phospholipid binding |
2. P | GO:0048545 | response to steroid hormone |
2. P | GO:2000986 | negative regulation of behavioral fear response |
2. P | GO:0002366 | leukocyte activation involved in immune response |
2. P | GO:0008628 | hormone-mediated apoptotic signaling pathway |
2. P | GO:0001659 | temperature homeostasis |
2. P | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity |
2. P | GO:0008200 | ion channel inhibitor activity |
2. P | GO:0048662 | negative regulation of smooth muscle cell proliferation |
2. P | GO:0060550 | positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity |
2. P | GO:0032489 | regulation of Cdc42 protein signal transduction |
2. P | GO:0005737 | cytoplasm |
2. P | GO:0033344 | cholesterol efflux |
2. P | GO:0050766 | positive regulation of phagocytosis |
2. P | GO:0032571 | response to vitamin K |
2. P | GO:0070378 | positive regulation of ERK5 cascade |
2. P | GO:0005504 | fatty acid binding |
2. P | GO:0030308 | negative regulation of cell growth |
2. P | GO:0042995 | cell projection |
2. P | GO:0060697 | positive regulation of phospholipid catabolic process |
2. P | GO:0044619 | positive regulation of relaxation of uterine smooth muscle in another organism |
2. P | GO:0071878 | negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway |
2. P | GO:0008203 | cholesterol metabolic process |
2. P | GO:0034364 | high-density lipoprotein particle |
2. P | GO:0016521 | pituitary adenylate cyclase activating polypeptide activity |
2. P | GO:0043508 | negative regulation of JUN kinase activity |
2. P | GO:1900076 | regulation of cellular response to insulin stimulus |
2. P | GO:1990008 | neurosecretory vesicle |
2. P | GO:0031836 | neuromedin K receptor binding |
2. P | GO:0009755 | hormone-mediated signaling pathway |
2. P | GO:0001649 | osteoblast differentiation |
2. P | GO:0033280 | response to vitamin D |
2. P | GO:0045087 | innate immune response |
2. P | GO:1902608 | positive regulation of large conductance calcium-activated potassium channel activity |
2. P | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus |
2. P | GO:0008035 | high-density lipoprotein particle binding |
2. P | GO:0045823 | positive regulation of heart contraction |
2. P | GO:0032722 | positive regulation of chemokine production |
2. P | GO:0071222 | cellular response to lipopolysaccharide |
2. P | GO:0090290 | positive regulation of osteoclast proliferation |
2. P | GO:0003161 | cardiac conduction system development |
2. P | GO:0005135 | interleukin-3 receptor binding |
2. P | GO:0009416 | response to light stimulus |
2. P | GO:2000352 | negative regulation of endothelial cell apoptotic process |
2. P | GO:0033594 | response to hydroxyisoflavone |
2. P | GO:0045717 | negative regulation of fatty acid biosynthetic process |
2. P | GO:0030500 | regulation of bone mineralization |
2. P | GO:0045672 | positive regulation of osteoclast differentiation |
2. P | GO:1902004 | positive regulation of amyloid-beta formation |
2. P | GO:0051901 | positive regulation of mitochondrial depolarization |
2. P | GO:0050821 | protein stabilization |
2. P | GO:0004966 | galanin receptor activity |
2. P | GO:0009967 | positive regulation of signal transduction |
2. P | GO:1990834 | response to odorant |
2. P | GO:0045668 | negative regulation of osteoblast differentiation |
2. P | GO:1900738 | positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway |
2. P | GO:0110150 | negative regulation of biomineralization |
2. P | GO:0045187 | regulation of circadian sleep/wake cycle, sleep |
2. P | GO:0000187 | obsolete activation of MAPK activity |
2. P | GO:0008285 | negative regulation of cell population proliferation |
2. P | GO:0007168 | receptor guanylyl cyclase signaling pathway |
2. P | GO:0051873 | killing by host of symbiont cells |
2. P | GO:0031837 | substance K receptor binding |
2. P | GO:1901841 | regulation of high voltage-gated calcium channel activity |
2. P | GO:0070328 | triglyceride homeostasis |
2. P | GO:0045968 | negative regulation of juvenile hormone biosynthetic process |
2. P | GO:0021984 | adenohypophysis development |
2. P | GO:0043400 | cortisol secretion |
2. P | GO:0060455 | negative regulation of gastric acid secretion |
2. P | GO:2000424 | positive regulation of eosinophil chemotaxis |
2. P | GO:0046340 | diacylglycerol catabolic process |
2. P | GO:1903999 | negative regulation of eating behavior |
2. P | GO:0031768 | ghrelin receptor binding |
2. P | GO:0045833 | negative regulation of lipid metabolic process |
2. P | GO:0031640 | killing of cells of another organism |
2. P | GO:0031045 | dense core granule |
2. P | GO:0043204 | perikaryon |
2. P | GO:2000320 | negative regulation of T-helper 17 cell differentiation |
2. P | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization |
2. P | GO:0031788 | motilin receptor binding |
2. P | GO:0043679 | axon terminus |
2. P | GO:0090729 | toxin activity |
2. P | GO:0030154 | cell differentiation |
2. P | GO:0055062 | phosphate ion homeostasis |
2. P | GO:0019433 | triglyceride catabolic process |
2. P | GO:1904798 | positive regulation of core promoter binding |
2. P | GO:0032094 | response to food |
2. P | GO:0009648 | photoperiodism |
2. P | GO:2000184 | positive regulation of progesterone biosynthetic process |
2. P | GO:0060452 | positive regulation of cardiac muscle contraction |
2. P | GO:0005798 | Golgi-associated vesicle |
2. P | GO:0031334 | positive regulation of protein-containing complex assembly |
2. P | GO:0032375 | negative regulation of cholesterol transport |
2. P | GO:0046326 | positive regulation of glucose import |
2. P | GO:0016021 | integral component of membrane |
2. P | GO:0042113 | B cell activation |
2. P | GO:0008284 | positive regulation of cell population proliferation |
2. P | GO:0031773 | kisspeptin receptor binding |
2. P | GO:0031175 | neuron projection development |
2. P | GO:0001664 | G protein-coupled receptor binding |
2. P | GO:0001503 | ossification |
2. P | GO:0007186 | G protein-coupled receptor signaling pathway |
2. P | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response |
2. P | GO:0002213 | defense response to insect |
2. P | GO:0062023 | collagen-containing extracellular matrix |
2. P | GO:0048143 | astrocyte activation |
2. P | GO:0090274 | positive regulation of somatostatin secretion |
2. P | GO:0031960 | response to corticosteroid |
2. P | GO:0042742 | defense response to bacterium |
2. P | GO:0006182 | cGMP biosynthetic process |
2. P | GO:0031214 | biomineral tissue development |
2. P | GO:0042599 | lamellar body |
2. P | GO:0048364 | root development |
2. P | GO:0004859 | phospholipase inhibitor activity |
2. P | GO:0051005 | negative regulation of lipoprotein lipase activity |
2. P | GO:0031844 | type 4 neuropeptide Y receptor binding |
2. P | GO:1903815 | negative regulation of collecting lymphatic vessel constriction |
2. P | GO:0010459 | negative regulation of heart rate |
2. P | GO:0034370 | triglyceride-rich lipoprotein particle remodeling |
2. P | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus |
2. P | GO:0002250 | adaptive immune response |
2. P | GO:0001937 | negative regulation of endothelial cell proliferation |
2. P | GO:0034361 | very-low-density lipoprotein particle |
2. P | GO:0040008 | regulation of growth |
2. P | GO:0046697 | decidualization |
2. P | GO:0050829 | defense response to Gram-negative bacterium |
2. P | GO:0008047 | enzyme activator activity |
2. P | GO:0120058 | positive regulation of small intestinal transit |
2. P | GO:0019934 | cGMP-mediated signaling |
2. P | GO:0001696 | gastric acid secretion |
2. P | GO:0043691 | reverse cholesterol transport |
2. P | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis |
2. P | GO:0002026 | regulation of the force of heart contraction |
2. P | GO:0034379 | very-low-density lipoprotein particle assembly |
2. P | GO:0006953 | acute-phase response |
2. P | GO:0042756 | drinking behavior |
2. P | GO:0003105 | negative regulation of glomerular filtration |
2. P | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation |
2. P | GO:1904346 | positive regulation of gastric mucosal blood circulation |
2. P | GO:1904306 | positive regulation of gastro-intestinal system smooth muscle contraction |
2. P | GO:0007268 | chemical synaptic transmission |
2. P | GO:0099170 | postsynaptic modulation of chemical synaptic transmission |
2. P | GO:0003085 | negative regulation of systemic arterial blood pressure |
2. P | GO:0042600 | egg chorion |
2. P | GO:1904349 | positive regulation of small intestine smooth muscle contraction |
2. P | GO:0002227 | innate immune response in mucosa |
2. P | GO:0060392 | negative regulation of SMAD protein signal transduction |
2. P | GO:0032903 | regulation of nerve growth factor production |
2. P | GO:0018158 | protein oxidation |
2. P | GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide |
2. P | GO:0007588 | excretion |
2. P | GO:0035176 | social behavior |
2. P | GO:0010960 | magnesium ion homeostasis |
2. P | GO:0071859 | neuropeptide F receptor binding |
2. P | GO:0043657 | host cell |
2. P | GO:0007202 | activation of phospholipase C activity |
2. P | GO:0008147 | structural constituent of bone |
2. P | GO:0035810 | positive regulation of urine volume |
2. P | GO:0050796 | regulation of insulin secretion |
2. P | GO:0001836 | release of cytochrome c from mitochondria |
2. P | GO:0006962 | male-specific antibacterial humoral response |
2. P | GO:0010890 | positive regulation of sequestering of triglyceride |
2. P | GO:0031145 | anaphase-promoting complex-dependent catabolic process |
2. P | GO:0002878 | negative regulation of acute inflammatory response to non-antigenic stimulus |
2. P | GO:1904014 | response to serotonin |
2. P | GO:0030103 | vasopressin secretion |
2. P | GO:0007217 | tachykinin receptor signaling pathway |
2. P | GO:0033686 | positive regulation of luteinizing hormone secretion |
2. P | GO:0034384 | high-density lipoprotein particle clearance |
2. P | GO:1902093 | positive regulation of flagellated sperm motility |
2. P | GO:0005125 | cytokine activity |
2. P | GO:1904058 | positive regulation of sensory perception of pain |
2. P | GO:2000280 | regulation of root development |
2. P | GO:0002674 | negative regulation of acute inflammatory response |
2. P | GO:0060124 | positive regulation of growth hormone secretion |
2. P | GO:0016358 | dendrite development |
2. P | GO:1902722 | positive regulation of prolactin secretion |
2. P | GO:0031841 | neuropeptide Y receptor binding |
2. P | GO:0044179 | hemolysis in another organism |
2. P | GO:0042595 | behavioral response to starvation |
2. P | GO:0034645 | cellular macromolecule biosynthetic process |
2. P | GO:0035815 | positive regulation of renal sodium excretion |
2. P | GO:0008255 | ecdysis-triggering hormone activity |
2. P | GO:0010634 | positive regulation of epithelial cell migration |
2. P | GO:0034374 | low-density lipoprotein particle remodeling |
2. P | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness |
2. P | GO:0034366 | spherical high-density lipoprotein particle |
2. P | GO:0007275 | multicellular organism development |
2. P | GO:0051447 | negative regulation of meiotic cell cycle |
2. P | GO:0045471 | response to ethanol |
2. P | GO:0120069 | positive regulation of stomach fundus smooth muscle contraction |
2. P | GO:1901216 | positive regulation of neuron death |
2. P | GO:0002281 | macrophage activation involved in immune response |
2. P | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep |
2. P | GO:0070314 | G1 to G0 transition |
2. P | GO:2000843 | regulation of testosterone secretion |
2. P | GO:1901698 | response to nitrogen compound |
2. P | GO:0071902 | positive regulation of protein serine/threonine kinase activity |
2. P | GO:1903012 | positive regulation of bone development |
2. P | GO:0045348 | positive regulation of MHC class II biosynthetic process |
2. P | GO:0045906 | negative regulation of vasoconstriction |
2. P | GO:0009617 | response to bacterium |
2. P | GO:0050806 | positive regulation of synaptic transmission |
2. P | GO:2000252 | negative regulation of feeding behavior |
2. P | GO:0032224 | positive regulation of synaptic transmission, cholinergic |
2. P | GO:0031854 | orexigenic neuropeptide QRFP receptor binding |
2. P | GO:0060079 | excitatory postsynaptic potential |
2. P | GO:0008083 | growth factor activity |
2. P | GO:0040010 | positive regulation of growth rate |
2. P | GO:0021987 | cerebral cortex development |
2. P | GO:0021954 | central nervous system neuron development |
2. P | GO:0002024 | diet induced thermogenesis |
2. P | GO:0016608 | growth hormone-releasing hormone activity |
2. P | GO:0042627 | chylomicron |
2. P | GO:0005739 | mitochondrion |
2. P | GO:0030225 | macrophage differentiation |
2. P | GO:0031857 | type 1 parathyroid hormone receptor binding |
2. P | GO:0055102 | lipase inhibitor activity |
2. P | GO:0003084 | positive regulation of systemic arterial blood pressure |
2. P | GO:0008049 | male courtship behavior |
2. P | GO:0033612 | receptor serine/threonine kinase binding |
2. P | GO:0090187 | positive regulation of pancreatic juice secretion |
2. P | GO:0051726 | regulation of cell cycle |
2. P | GO:1904000 | positive regulation of eating behavior |
2. P | GO:1901218 | negative regulation of holin activity |
2. P | GO:0034382 | chylomicron remnant clearance |
2. P | GO:0051930 | regulation of sensory perception of pain |
2. P | GO:0031667 | response to nutrient levels |
2. P | GO:0051427 | hormone receptor binding |
2. P | GO:0031765 | type 2 galanin receptor binding |
2. P | GO:0018206 | peptidyl-methionine modification |
2. P | GO:0010508 | positive regulation of autophagy |
2. P | GO:0048706 | embryonic skeletal system development |
2. P | GO:0034363 | intermediate-density lipoprotein particle |
2. P | GO:0038002 | endocrine signaling |
2. P | GO:0050672 | negative regulation of lymphocyte proliferation |
2. P | GO:0046848 | hydroxyapatite binding |
2. P | GO:0007565 | female pregnancy |
2. P | GO:0035864 | response to potassium ion |
2. P | GO:0032720 | negative regulation of tumor necrosis factor production |
2. P | GO:0032755 | positive regulation of interleukin-6 production |
2. P | GO:2001223 | negative regulation of neuron migration |
2. P | GO:0034190 | apolipoprotein receptor binding |
2. P | GO:0035811 | negative regulation of urine volume |
2. P | GO:0048572 | short-day photoperiodism |
2. P | GO:0003416 | endochondral bone growth |
2. P | GO:0031878 | type 1 somatostatin receptor binding |
2. P | GO:0009725 | response to hormone |
2. P | GO:0050878 | regulation of body fluid levels |
2. P | GO:0035896 | positive regulation of mast cell degranulation in another organism |
2. P | GO:0031843 | type 2 neuropeptide Y receptor binding |
2. P | GO:0030141 | secretory granule |
2. P | GO:1903640 | negative regulation of gastrin-induced gastric acid secretion |
2. P | GO:0050996 | positive regulation of lipid catabolic process |
2. P | GO:0043194 | axon initial segment |
2. P | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel |
2. P | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein |
2. P | GO:0090277 | positive regulation of peptide hormone secretion |
2. P | GO:0031856 | parathyroid hormone receptor binding |
2. P | GO:0043306 | positive regulation of mast cell degranulation |
2. P | GO:0042811 | pheromone biosynthetic process |
2. P | GO:0032096 | negative regulation of response to food |
2. P | GO:0043031 | negative regulation of macrophage activation |
2. P | GO:0006955 | immune response |
2. P | GO:1903595 | positive regulation of histamine secretion by mast cell |
2. P | GO:0000003 | reproduction |
2. P | GO:0032834 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response |
2. P | GO:0008343 | adult feeding behavior |
2. P | GO:0034393 | positive regulation of smooth muscle cell apoptotic process |
2. P | GO:0015485 | cholesterol binding |
2. P | GO:0010873 | positive regulation of cholesterol esterification |
2. P | GO:0045777 | positive regulation of blood pressure |
2. P | GO:0051461 | positive regulation of corticotropin secretion |
2. P | GO:1902025 | nitrate import |
2. P | GO:0043950 | positive regulation of cAMP-mediated signaling |
2. P | GO:0006642 | triglyceride mobilization |
2. P | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep |
2. P | GO:0060457 | negative regulation of digestive system process |
2. P | GO:0045064 | T-helper 2 cell differentiation |
2. P | GO:0098992 | neuronal dense core vesicle |
2. P | GO:0030298 | receptor signaling protein tyrosine kinase activator activity |
2. P | GO:0032095 | regulation of response to food |
2. P | GO:1905564 | positive regulation of vascular endothelial cell proliferation |
2. P | GO:0060575 | intestinal epithelial cell differentiation |
2. P | GO:0006972 | hyperosmotic response |
2. P | GO:0060976 | coronary vasculature development |
2. P | GO:0006869 | lipid transport |
2. P | GO:0008613 | diuretic hormone activity |
2. P | GO:0048018 | receptor ligand activity |
2. P | GO:0008154 | actin polymerization or depolymerization |
2. P | GO:0071858 | corazonin receptor binding |
2. P | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling |
2. P | GO:0030250 | guanylate cyclase activator activity |
2. P | GO:0099175 | regulation of postsynapse organization |
2. P | GO:0120162 | positive regulation of cold-induced thermogenesis |
2. P | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production |
2. P | GO:0031764 | type 1 galanin receptor binding |
2. P | GO:0035483 | gastric emptying |
2. P | GO:0006995 | cellular response to nitrogen starvation |
2. P | GO:0032098 | regulation of appetite |
2. P | GO:0071774 | response to fibroblast growth factor |
2. P | GO:0046659 | digestive hormone activity |
2. P | GO:0051464 | positive regulation of cortisol secretion |
2. P | GO:0034774 | secretory granule lumen |
2. P | GO:0003419 | growth plate cartilage chondrocyte proliferation |
2. P | GO:1900194 | negative regulation of oocyte maturation |
2. P | GO:0032868 | response to insulin |
2. P | GO:0050728 | negative regulation of inflammatory response |
2. P | GO:0031839 | type 1 neuromedin U receptor binding |
2. P | GO:0045429 | positive regulation of nitric oxide biosynthetic process |
2. P | GO:0042748 | circadian sleep/wake cycle, non-REM sleep |
2. P | GO:1903860 | negative regulation of dendrite extension |
2. P | GO:0030536 | larval feeding behavior |
2. P | GO:0032715 | negative regulation of interleukin-6 production |
2. P | GO:0034447 | very-low-density lipoprotein particle clearance |
2. P | GO:0031296 | B cell costimulation |
2. P | GO:0032757 | positive regulation of interleukin-8 production |
2. P | GO:0048304 | positive regulation of isotype switching to IgG isotypes |
2. P | GO:0051795 | positive regulation of timing of catagen |
2. P | GO:0034014 | response to triglyceride |
2. P | GO:0010989 | negative regulation of low-density lipoprotein particle clearance |
2. P | GO:0022414 | reproductive process |
2. P | GO:0051607 | defense response to virus |
2. P | GO:0044539 | long-chain fatty acid import into cell |
2. P | GO:0040018 | positive regulation of multicellular organism growth |
2. P | GO:0071864 | positive regulation of cell proliferation in bone marrow |
2. P | GO:0050832 | defense response to fungus |
2. P | GO:2000354 | regulation of ovarian follicle development |
2. P | GO:0048295 | positive regulation of isotype switching to IgE isotypes |
2. P | GO:0051712 | positive regulation of killing of cells of another organism |
2. P | GO:1904407 | positive regulation of nitric oxide metabolic process |
2. P | GO:2000854 | positive regulation of corticosterone secretion |
2. P | GO:0007589 | body fluid secretion |
2. P | GO:0032099 | negative regulation of appetite |
2. P | GO:0031858 | pituitary adenylate cyclase-activating polypeptide receptor binding |
2. P | GO:0009992 | cellular water homeostasis |
2. P | GO:0071107 | response to parathyroid hormone |
2. P | GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep |
2. P | GO:0033087 | negative regulation of immature T cell proliferation |
2. P | GO:0031943 | regulation of glucocorticoid metabolic process |
2. P | GO:0031770 | growth hormone-releasing hormone receptor binding |
2. P | GO:0051969 | regulation of transmission of nerve impulse |
2. P | GO:0005829 | cytosol |
2. P | GO:0047485 | protein N-terminus binding |
2. P | GO:0042922 | neuromedin U receptor binding |
2. P | GO:0046872 | metal ion binding |
2. P | GO:0051673 | membrane disruption in another organism |
2. P | GO:0031700 | adrenomedullin receptor binding |
2. P | GO:2000821 | regulation of grooming behavior |
2. P | GO:0070653 | high-density lipoprotein particle receptor binding |
2. P | GO:0030501 | positive regulation of bone mineralization |
2. P | GO:0032024 | positive regulation of insulin secretion |
2. P | GO:0071351 | cellular response to interleukin-18 |
2. P | GO:0031840 | type 2 neuromedin U receptor binding |
2. P | GO:0010897 | negative regulation of triglyceride catabolic process |
2. P | GO:1903660 | negative regulation of complement-dependent cytotoxicity |
3. B | GO:0002031 | G protein-coupled receptor internalization |
3. B | GO:0016234 | inclusion body |
3. B | GO:0001944 | vasculature development |
3. B | GO:0010823 | negative regulation of mitochondrion organization |
3. B | GO:0032730 | positive regulation of interleukin-1 alpha production |
3. B | GO:0051260 | protein homooligomerization |
3. B | GO:0043542 | endothelial cell migration |
3. B | GO:0010739 | positive regulation of protein kinase A signaling |
3. B | GO:0045892 | negative regulation of transcription, DNA-templated |
3. B | GO:0048240 | sperm capacitation |
3. B | GO:0071356 | cellular response to tumor necrosis factor |
3. B | GO:1905907 | negative regulation of amyloid fibril formation |
3. B | GO:0007159 | leukocyte cell-cell adhesion |
3. B | GO:0010942 | positive regulation of cell death |
3. B | GO:0033138 | positive regulation of peptidyl-serine phosphorylation |
3. B | GO:1905665 | positive regulation of calcium ion import across plasma membrane |
3. B | GO:0045651 | positive regulation of macrophage differentiation |
3. B | GO:0001935 | endothelial cell proliferation |
3. B | GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
3. B | GO:0010523 | negative regulation of calcium ion transport into cytosol |
3. B | GO:1990000 | amyloid fibril formation |
3. B | GO:1990408 | calcitonin gene-related peptide receptor signaling pathway |
3. B | GO:0051897 | positive regulation of protein kinase B signaling |
3. B | GO:0031648 | protein destabilization |
3. B | GO:0045596 | negative regulation of cell differentiation |
3. B | GO:0032147 | activation of protein kinase activity |
3. B | GO:0042802 | identical protein binding |
Homologs
1. PB indicates the homologs that are found by both PROST and BLAST.
2. P indicates homologs that are only found by PROST.
3. B indicates homologs that are only found by BLAST.
Source | Homolog | Description | FATCAT p-val | PROST Evalue | BLAST Evalue |
---|---|---|---|---|---|
1. PB | Q9N0T3 | Calcitonin gene-related peptide 2 | 1.31e-08 | 1.05e-45 | 7.93e-55 |
1. PB | Q99JA0 | Calcitonin gene-related peptide 1 | 2.83e-08 | 1.91e-47 | 5.73e-57 |
1. PB | P17716 | Islet amyloid polypeptide | 4.59e-03 | 1.17e-02 | 1.92e-07 |
1. PB | P06881 | Calcitonin gene-related peptide 1 | 0 | 4.76e-115 | 4.64e-90 |
1. PB | Q75V94 | Calcitonin receptor-stimulating peptide 1 | 1.55e-06 | 4.81e-37 | 8.10e-53 |
1. PB | P07660 | Calcitonin | 1.46e-03 | 1.06e-21 | 4.31e-16 |
1. PB | Q766Y6 | Calcitonin receptor-stimulating peptide 3 | 1.05e-06 | 3.34e-33 | 2.31e-54 |
1. PB | P22889 | Islet amyloid polypeptide | 8.72e-03 | 8.79e-04 | 1.06e-05 |
1. PB | P01258 | Calcitonin | 5.45e-06 | 4.78e-31 | 4.61e-48 |
1. PB | P01261 | Calcitonin | 4.71e-04 | 2.14e-24 | 1.59e-20 |
1. PB | P70160 | Calcitonin | 5.49e-05 | 1.17e-20 | 3.33e-21 |
1. PB | P23442 | Islet amyloid polypeptide | 1.88e-02 | 2.20e-02 | 7.62e-08 |
1. PB | Q99MP3 | Calcitonin gene-related peptide 2 | 6.71e-07 | 1.12e-40 | 3.49e-56 |
1. PB | P12969 | Islet amyloid polypeptide | 2.46e-02 | 9.58e-05 | 3.57e-07 |
1. PB | P10286 | Calcitonin gene-related peptide | 2.58e-08 | 3.10e-44 | 8.02e-48 |
1. PB | Q75V95 | Calcitonin receptor-stimulating peptide 1 | 1.09e-05 | 4.71e-30 | 1.46e-50 |
1. PB | P10093 | Calcitonin gene-related peptide 2 | 2.32e-09 | 1.93e-37 | 3.39e-55 |
1. PB | P10092 | Calcitonin gene-related peptide 2 | 6.18e-10 | 8.57e-65 | 4.88e-76 |
1. PB | B3IWF7 | Calcitonin receptor-stimulating peptide 1 | 1.18e-05 | 2.85e-28 | 3.04e-50 |
1. PB | P81564 | Skin calcitonin gene-related peptide | 1.20e-06 | 8.29e-25 | 8.95e-22 |
1. PB | Q9MYV1 | Calcitonin gene-related peptide 1 | 2.54e-09 | 1.83e-50 | 1.54e-57 |
1. PB | P01257 | Calcitonin | 2.69e-04 | 2.47e-27 | 9.43e-20 |
1. PB | P41547 | Calcitonin | 2.17e-04 | 4.81e-35 | 6.85e-21 |
1. PB | B3IWF9 | Calcitonin receptor-stimulating peptide 1 | 9.75e-06 | 3.60e-28 | 4.00e-50 |
1. PB | Q75V93 | Calcitonin receptor-stimulating peptide 2 | 1.36e-05 | 1.22e-23 | 1.02e-47 |
1. PB | P01263 | Calcitonin-1 | 6.28e-04 | 2.31e-26 | 8.52e-15 |
1. PB | Q9N0T2 | Calcitonin gene-related peptide 1 | 2.46e-04 | 1.93e-37 | 2.36e-57 |
1. PB | B3IWF8 | Calcitonin receptor-stimulating peptide 2 | 5.51e-09 | 1.26e-25 | 1.39e-51 |
1. PB | Q9N0V5 | Calcitonin | 4.95e-04 | 4.49e-24 | 2.19e-32 |
1. PB | Q862B1 | Calcitonin receptor-stimulating peptide 1 | 2.21e-07 | 1.08e-31 | 4.74e-53 |
1. PB | P01256 | Calcitonin gene-related peptide 1 | 4.11e-10 | 6.38e-51 | 5.03e-69 |
1. PB | Q766Y7 | Calcitonin receptor-stimulating peptide 2 | 2.12e-06 | 1.52e-30 | 6.05e-48 |
2. P | D2Y240 | U3-theraphotoxin-Hhn1a 1 | 1.40e-01 | 1.69e-02 | NA |
2. P | Q9BQ08 | Resistin-like beta | 2.39e-02 | 1.37e-02 | NA |
2. P | P02652 | Apolipoprotein A-II | 2.39e-03 | 1.66e-04 | NA |
2. P | D2Y2I9 | U4-theraphotoxin-Hhn1a | 1.32e-05 | 5.13e-03 | NA |
2. P | E2AX75 | Pigment-dispersing hormone peptides | 1.08e-02 | 6.34e-03 | NA |
2. P | P67792 | Cecropin-B | 1.14e-02 | 1.48e-02 | NA |
2. P | P51917 | Progonadoliberin-3 | 5.73e-03 | 3.36e-05 | NA |
2. P | Q16661 | Guanylate cyclase activator 2B | 7.13e-02 | 4.63e-02 | NA |
2. P | Q16RI5 | Adipokinetic hormone/corazonin-related peptide | NA | 1.31e-02 | NA |
2. P | Q0Q4F1 | Non-structural protein 3a | NA | 7.11e-06 | NA |
2. P | P0CJ08 | Venom protein 29 | 6.11e-02 | 1.84e-02 | NA |
2. P | D2Y244 | U3-theraphotoxin-Hhn1j | 9.57e-02 | 2.90e-02 | NA |
2. P | P07500 | Natriuretic peptides A | 1.97e-02 | 2.47e-06 | NA |
2. P | Q3ECD6 | CLAVATA3/ESR (CLE)-related protein 1 | 2.43e-04 | 2.00e-04 | NA |
2. P | D2Y2K7 | U4-theraphotoxin-Hhn1a | 1.28e-02 | 2.53e-02 | NA |
2. P | P04812 | Seminal vesicle secretory protein 5 | 4.88e-01 | 3.54e-03 | NA |
2. P | P37042 | Progonadoliberin-1 | 3.26e-03 | 8.39e-03 | NA |
2. P | E2A3M7 | Myosuppressin | 2.15e-03 | 8.75e-03 | NA |
2. P | Q9R0R4 | Apelin | 2.07e-01 | 2.65e-02 | NA |
2. P | W4VRY9 | U9-barytoxin-Tl1a | NA | 6.24e-03 | NA |
2. P | Q8UW82 | Progonadoliberin-3 | 2.93e-02 | 3.64e-02 | NA |
2. P | A0A0D9S1R4 | Apolipoprotein C-IV | 7.07e-04 | 3.68e-04 | NA |
2. P | B3FIS7 | U5-theraphotoxin-Hs1b 2 | 5.21e-02 | 3.91e-02 | NA |
2. P | J3QPP8 | ALK and LTK ligand 1 | 1.33e-01 | 6.71e-04 | NA |
2. P | Q805D5 | C-type natriuretic peptide 2 | 6.31e-02 | 7.40e-06 | NA |
2. P | D0EXD3 | Antifungal protein | 7.46e-01 | 2.86e-02 | NA |
2. P | P22642 | Ventricular natriuretic peptide | 3.69e-03 | 2.42e-07 | NA |
2. P | Q1ELU3 | M-zodatoxin-Lt3a | 5.41e-02 | 4.07e-04 | NA |
2. P | Q9SZG4 | Putative phytosulfokines 4 | 1.31e-02 | 7.68e-11 | NA |
2. P | D0P1A8 | RxLR effector protein Avrblb2 | 6.05e-02 | 6.54e-05 | NA |
2. P | C8AW45 | Interferon gamma-related | 1.46e-02 | 9.68e-03 | NA |
2. P | Q70KG2 | Protein RAFTIN 1C (Fragment) | 9.68e-02 | 7.41e-04 | NA |
2. P | F1T150 | Esculentin-1ISb | 5.34e-04 | 2.81e-02 | NA |
2. P | P04560 | Prepro-urotensin II-alpha | 1.14e-02 | 5.00e-05 | NA |
2. P | P54615 | Osteocalcin-related protein | 3.64e-03 | 7.11e-12 | NA |
2. P | B3EWG0 | Red pigment-concentrating hormone | 1.86e-04 | 2.45e-02 | NA |
2. P | P02654 | Apolipoprotein C-I | 2.99e-03 | 7.91e-03 | NA |
2. P | P0DTS5 | Apolipoprotein C-III | 2.08e-03 | 5.63e-03 | NA |
2. P | W4VS46 | Toxin ICK-10 | 1.94e-02 | 3.39e-03 | NA |
2. P | Q9IAU2 | Trp-8 progonadoliberin | 8.22e-03 | 3.17e-02 | NA |
2. P | P0CV59 | Secreted RxLR effector protein 143 | 2.52e-02 | 6.36e-04 | NA |
2. P | P63309 | Interferon gamma | 9.20e-03 | 1.96e-02 | NA |
2. P | P0DKW0 | Apolipoprotein C-II | 2.07e-03 | 1.27e-03 | NA |
2. P | F5CPE8 | Natriuretic peptide | 2.35e-01 | 3.36e-03 | NA |
2. P | Q8NHW6 | Otospiralin | 4.01e-02 | 1.32e-04 | NA |
2. P | Q95335 | Progonadoliberin-1 | 1.30e-03 | 1.48e-04 | NA |
2. P | P53614 | Serum amyloid A-1 protein | 7.95e-03 | 1.96e-02 | NA |
2. P | P01303 | Pro-neuropeptide Y | 4.47e-03 | 7.26e-06 | NA |
2. P | P63310 | Interferon gamma | 2.04e-02 | 1.96e-02 | NA |
2. P | W4VSG7 | Conotoxin Vc1 | 6.30e-03 | 3.29e-04 | NA |
2. P | B1P1I3 | U31-theraphotoxin-Cg1a | 1.61e-02 | 3.20e-02 | NA |
2. P | P0DM83 | Apolipoprotein C-I | 1.58e-03 | 7.27e-05 | NA |
2. P | P83057 | Kininogen-2 | 2.73e-02 | 1.30e-02 | NA |
2. P | P0DTG3 | Apolipoprotein C-I | 3.20e-03 | 4.51e-03 | NA |
2. P | P33094 | Somatostatin | 1.06e-02 | 1.60e-07 | NA |
2. P | P0DPH0 | Apolipoprotein C-I | 1.88e-03 | 9.97e-04 | NA |
2. P | P70664 | Guanylin | 1.09e-01 | 1.94e-03 | NA |
2. P | A6YB85 | Alpha-defensin 1 | 3.04e-02 | 8.11e-03 | NA |
2. P | P04092 | Glucagon-2 | 1.65e-03 | 4.84e-06 | NA |
2. P | D2Y204 | U4-theraphotoxin-Hhn1a | 1.10e-02 | 2.53e-02 | NA |
2. P | Q9I8P2 | Peptide YY-A | 1.02e-02 | 1.25e-05 | NA |
2. P | P20968 | C-type natriuretic peptide 1 | 3.45e-03 | 1.25e-08 | NA |
2. P | P0DJG2 | Apolipoprotein A-II | 1.10e-02 | 1.66e-04 | NA |
2. P | A0A096P2H4 | Apolipoprotein C-II | 3.01e-03 | 7.41e-04 | NA |
2. P | B9TQX4 | Unique cartilage matrix-associated protein | 9.64e-04 | 6.40e-03 | NA |
2. P | M1E1F0 | U2-sicaritoxin-Sdo1a | 8.35e-03 | 7.64e-03 | NA |
2. P | Q9BDJ6 | Appetite-regulating hormone | 1.90e-03 | 1.83e-05 | NA |
2. P | P0C8U8 | Alpha-conotoxin-like Pu1.4 | 2.88e-02 | 1.41e-02 | NA |
2. P | Q9XT35 | Parathyroid hormone | 1.40e-03 | 2.14e-06 | NA |
2. P | Q8AYR5 | C-type natriuretic peptide 2 | 6.17e-03 | 8.88e-05 | NA |
2. P | G5BQH4 | Apolipoprotein C-III | 3.77e-03 | 1.50e-03 | NA |
2. P | P16860 | Natriuretic peptides B | 4.79e-03 | 4.20e-08 | NA |
2. P | Q8K559 | Otospiralin | 3.02e-02 | 2.12e-06 | NA |
2. P | P25140 | Interleukin-3 | 7.41e-02 | 8.47e-05 | NA |
2. P | P13562 | Progonadoliberin-1 | 1.29e-03 | 3.16e-03 | NA |
2. P | P02659 | Apovitellenin-1 | 1.93e-03 | 9.20e-04 | NA |
2. P | Q9EPS2 | Peptide YY | 1.21e-02 | 9.44e-03 | NA |
2. P | Q2V354 | Defensin-like protein 267 | 1.22e-02 | 1.68e-02 | NA |
2. P | C0HKT1 | Neuropeptide CCHamide-2 | 1.35e-02 | 2.95e-04 | NA |
2. P | P0DTG7 | Apolipoprotein C-I | 8.40e-03 | 7.34e-05 | NA |
2. P | P0CJ16 | Venom protein 49.1 | 6.38e-03 | 2.93e-02 | NA |
2. P | B3IXK1 | Interferon gamma | 4.88e-03 | 3.22e-03 | NA |
2. P | P43306 | Progonadoliberin-2 | 4.04e-02 | 4.37e-05 | NA |
2. P | Q8AYR6 | C-type natriuretic peptide 1 | 1.39e-02 | 1.81e-06 | NA |
2. P | P0DKW3 | Apolipoprotein C-IV | 1.28e-03 | 3.96e-03 | NA |
2. P | H6S3X4 | Secreted RxLR effector protein 18 | 3.43e-02 | 7.97e-04 | NA |
2. P | P50145 | Cholecystokinin B | 1.82e-02 | 1.01e-04 | NA |
2. P | Q8R5G8 | Guanylate cyclase activator 2B | 6.43e-02 | 4.62e-04 | NA |
2. P | P16613 | Pituitary adenylate cyclase-activating polypeptide | 2.25e-03 | 1.52e-03 | NA |
2. P | Q9TUI9 | Apelin | 1.09e-01 | 2.68e-02 | NA |
2. P | O42471 | Progonadoliberin IIB | 3.89e-02 | 3.26e-04 | NA |
2. P | P0DN97 | Precursor of CEP8 | 4.04e-02 | 6.18e-03 | NA |
2. P | Q90ZY0 | Pleurocidin | 3.60e-03 | 2.90e-02 | NA |
2. P | P0DSK7 | U-myrmeciitoxin(01)-Mg9a | 5.00e-02 | 1.98e-02 | NA |
2. P | P0CI14 | Augerpeptide Hhe9a | 6.79e-02 | 1.00e-02 | NA |
2. P | C7C1L2 | Probable antimicrobial peptide Con13 | 1.06e-01 | 1.24e-02 | NA |
2. P | Q9YGH4 | Somatostatin-2 | 1.57e-02 | 3.11e-05 | NA |
2. P | A0A1L2F565 | Parathyroid hormone 4 | 1.13e-03 | 1.61e-09 | NA |
2. P | P0DM82 | Apolipoprotein C-I | 1.30e-02 | 5.00e-03 | NA |
2. P | Q29B55 | Neuropeptide F | 2.02e-04 | 8.18e-04 | NA |
2. P | P42161 | Interferon gamma | 1.46e-02 | 1.86e-03 | NA |
2. P | P06740 | Interleukin-3 | 1.25e-02 | 1.89e-05 | NA |
2. P | P58457 | Kalata-B7 | 2.55e-03 | 2.42e-03 | NA |
2. P | Q7M742 | Secretoglobin family 1C member 1 | 6.78e-03 | 4.70e-02 | NA |
2. P | P55099 | Tachykinin-3 | 1.08e-02 | 5.50e-04 | NA |
2. P | Q800I8 | C-type natriuretic peptide 3 | 1.18e-03 | 2.07e-04 | NA |
2. P | A0A0P1AK67 | Secreted RxLR effector protein RXLR-C22 | 4.34e-03 | 9.84e-03 | NA |
2. P | B4G532 | Protein Turandot X | 6.81e-03 | 1.24e-02 | NA |
2. P | Q1ELU0 | M-zodatoxin-Lt2b | 3.29e-03 | 2.35e-02 | NA |
2. P | Q8R448 | Otospiralin | 2.21e-02 | 1.09e-04 | NA |
2. P | P0DTQ5 | Apolipoprotein C-II | 2.65e-04 | 3.00e-03 | NA |
2. P | P0DN57 | Teretoxin Tan9.6 | 2.20e-02 | 1.88e-02 | NA |
2. P | D2Y2M2 | U3-theraphotoxin-Hhn1b | 1.00e-01 | 3.08e-03 | NA |
2. P | Q8MKG2 | Uteroglobin | 5.82e-03 | 4.52e-02 | NA |
2. P | Q647G2 | Interferon gamma | 1.55e-02 | 2.52e-03 | NA |
2. P | D2Y219 | U4-theraphotoxin-Hhn1ac | 4.75e-03 | 4.79e-03 | NA |
2. P | P86336 | Apolipoprotein C-I, acidic form | 1.21e-03 | 2.31e-03 | NA |
2. P | Q9FRF9 | Phytosulfokines 3 | 5.58e-03 | 4.72e-05 | NA |
2. P | A0A193H329 | Cruzioseptin-8 | 7.35e-05 | 4.86e-05 | NA |
2. P | P79886 | Apovitellenin-1 | 2.85e-03 | 1.06e-08 | NA |
2. P | Q1ELU2 | M-zodatoxin-Lt3b | 2.10e-02 | 1.35e-04 | NA |
2. P | Q805E8 | Brain natriuretic peptide | 1.16e-02 | 1.91e-10 | NA |
2. P | Q08535 | Secretin | 2.69e-03 | 7.86e-10 | NA |
2. P | B6GXZ8 | Antifungal protein | 4.13e-01 | 7.52e-03 | NA |
2. P | Q5G866 | Alpha-defensin 23 | 2.82e-01 | 2.75e-03 | NA |
2. P | Q9UHF0 | Tachykinin-3 | 2.62e-03 | 3.36e-05 | NA |
2. P | P0DP86 | Apolipoprotein A-II | 1.89e-02 | 4.32e-03 | NA |
2. P | P0DN40 | Apolipoprotein C-II | 5.59e-03 | 9.05e-06 | NA |
2. P | P18313 | Sapecin | 3.34e-02 | 4.35e-03 | NA |
2. P | P48097 | Neuropeptide Y | 4.87e-03 | 4.41e-05 | NA |
2. P | P50707 | Alpha-defensin 9 | 1.87e-01 | 4.70e-03 | NA |
2. P | P0DMP9 | Apolipoprotein C-III | 1.17e-03 | 5.98e-03 | NA |
2. P | P81490 | Dermaseptin-B6 | 1.42e-04 | 8.25e-03 | NA |
2. P | P18659 | Apolipoprotein C-III | 1.88e-03 | 4.12e-05 | NA |
2. P | P49112 | Neutrophil cationic peptide 2 | 2.94e-01 | 6.79e-03 | NA |
2. P | B1P1I1 | U30-theraphotoxin-Cg1a | 1.34e-01 | 1.87e-02 | NA |
2. P | D0NIW0 | RxLR effector protein Avr10 | 1.63e-01 | 2.29e-02 | NA |
2. P | P06307 | Cholecystokinin | 7.47e-03 | 5.50e-05 | NA |
2. P | P13205 | Natriuretic peptides B | 8.16e-03 | 5.73e-14 | NA |
2. P | P12279 | Apolipoprotein C-III | 8.70e-04 | 1.01e-04 | NA |
2. P | O42241 | Progonadoliberin-2 | 2.37e-02 | 9.31e-05 | NA |
2. P | P25132 | 12.0 kDa protein | NA | 2.45e-02 | NA |
2. P | Q0VBW8 | Neuromedin-S | 2.38e-02 | 8.38e-12 | NA |
2. P | Q8I6S3 | Tachykinin-1 | 1.70e-04 | 8.55e-05 | NA |
2. P | P01269 | Parathyroid hormone | 6.03e-04 | 8.27e-11 | NA |
2. P | D2Y224 | U4-theraphotoxin-Hhn1e | 2.04e-05 | 2.65e-02 | NA |
2. P | P51694 | Peptide YY | 6.67e-02 | 7.70e-05 | NA |
2. P | P0CD95 | Uncharacterized protein C17orf67 homolog | 9.56e-05 | 7.62e-04 | NA |
2. P | P84020 | Cecropin-C | 1.15e-02 | 2.83e-03 | NA |
2. P | P0DM93 | Apolipoprotein A-II | 1.60e-02 | 4.00e-03 | NA |
2. P | P0DP50 | Apolipoprotein A-II | 4.39e-04 | 9.60e-03 | NA |
2. P | P07095 | Blood plasma apolipoprotein LAL1 | 3.78e-03 | 1.07e-07 | NA |
2. P | P87385 | Somatostatin-2 | 9.32e-04 | 4.94e-06 | NA |
2. P | A0A348G5W0 | U-poneritoxin(01)-Om4a | 1.70e-03 | 7.20e-03 | NA |
2. P | B5LUR1 | Preprofallaxidin-9 | 1.42e-02 | 3.58e-02 | NA |
2. P | P0DTG6 | Apolipoprotein C-I | 6.21e-03 | 9.44e-03 | NA |
2. P | Q4G0G5 | Secretoglobin family 2B member 2 | 2.25e-01 | 6.42e-05 | NA |
2. P | B1P1F0 | U15-theraphotoxin-Cg1a | 7.28e-02 | 4.82e-02 | NA |
2. P | Q9PT98 | Peptide Y | 1.09e-02 | 1.26e-03 | NA |
2. P | P07480 | Galanin peptides | 1.09e-02 | 2.93e-03 | NA |
2. P | P15743 | Parathyroid hormone | 8.63e-04 | 1.57e-11 | NA |
2. P | P86039 | Raniseptin-6 | 4.95e-04 | 8.60e-03 | NA |
2. P | P01168 | Somatostatin | 9.20e-03 | 2.88e-06 | NA |
2. P | Q9VDH4 | Protein Turandot B | 1.82e-02 | 4.50e-04 | NA |
2. P | P55208 | C-type natriuretic peptide prohormone | 3.44e-02 | 9.20e-08 | NA |
2. P | P84224 | Cecropin-C | 5.96e-04 | 5.88e-03 | NA |
2. P | Q9DGK7 | Pro-neuropeptide Y | 3.84e-03 | 6.42e-05 | NA |
2. P | G5EHH0 | Biotrophy-associated secreted protein 3 | 9.03e-01 | 9.13e-03 | NA |
2. P | P40585 | Seripauperin-15 | 1.67e-01 | 1.91e-02 | NA |
2. P | Q9NJC6 | Potassium channel toxin BmTXK-beta | 4.77e-03 | 4.04e-02 | NA |
2. P | Q8S8N1 | CLAVATA3/ESR (CLE)-related protein 7 | 5.60e-03 | 3.85e-04 | NA |
2. P | A0A084G2W8 | Fungal defensin scedosporisin-2 | 7.74e-01 | 4.34e-02 | NA |
2. P | Q9BPE3 | Conotoxin TsMLCL-03 | 3.75e-02 | 1.69e-02 | NA |
2. P | Q566V9 | Augurin-A | 1.68e-02 | 4.14e-04 | NA |
2. P | C0HKT4 | Diuretic hormone 41 | 1.08e-02 | 1.29e-02 | NA |
2. P | P07507 | Matrix Gla protein | 8.17e-03 | 7.78e-06 | NA |
2. P | W4VRV3 | U12-barytoxin-Tl1a | 5.20e-04 | 4.52e-02 | NA |
2. P | Q29W19 | Pituitary adenylate cyclase-activating polypeptide | 5.05e-03 | 1.27e-03 | NA |
2. P | Q9FS10 | Phytosulfokines | 1.53e-02 | 8.96e-06 | NA |
2. P | Q8K560 | Otospiralin | 1.22e-01 | 7.97e-04 | NA |
2. P | D2Y213 | U4-theraphotoxin-Hhn1aa | 1.29e-02 | 1.20e-03 | NA |
2. P | P0DJK0 | Sarafotoxin-i1 | 9.65e-02 | 1.78e-02 | NA |
2. P | P01270 | Parathyroid hormone | 1.33e-03 | 2.93e-07 | NA |
2. P | P47841 | Matrix Gla protein | 7.81e-03 | 2.11e-04 | NA |
2. P | P06303 | Pancreatic prohormone | 1.06e-03 | 1.12e-03 | NA |
2. P | Q9I9D3 | Pro-neuropeptide Y | 9.23e-04 | 1.54e-03 | NA |
2. P | P16240 | Cionin | 1.76e-02 | 4.39e-03 | NA |
2. P | Q1ELV0 | M-zodatoxin-Lt7a | 2.46e-03 | 4.51e-03 | NA |
2. P | G5BWH8 | Apolipoprotein A-II | 1.46e-02 | 7.02e-03 | NA |
2. P | Q01524 | Defensin-6 | 1.47e-01 | 3.79e-02 | NA |
2. P | F1QQI2 | Spexin prohormone 1 | 8.55e-04 | 2.27e-05 | NA |
2. P | A0A5P9K6A8 | Dermaseptin-SP4 | 4.40e-04 | 4.03e-04 | NA |
2. P | P0DM94 | Apolipoprotein A-II | 2.17e-03 | 5.13e-03 | NA |
2. P | P04089 | Parathyroid hormone | 5.07e-03 | 1.21e-10 | NA |
2. P | D2Y2G9 | U3-theraphotoxin-Hhn1p | 1.56e-01 | 2.90e-02 | NA |
2. P | Q800R2 | Caerin-1.1 | 2.04e-03 | 1.94e-02 | NA |
2. P | Q6Y4S4 | Metastasis-suppressor KiSS-1 | 1.96e-02 | 4.44e-08 | NA |
2. P | P91963 | Pigment-dispersing hormone type 1 | 2.14e-02 | 1.60e-02 | NA |
2. P | P33715 | Urotensin-2 | 1.22e-02 | 1.73e-05 | NA |
2. P | Q9R0R3 | Apelin | 1.54e-01 | 3.92e-04 | NA |
2. P | P86471 | Defensin Lucifensin | 1.02e-01 | 4.51e-03 | NA |
2. P | D2Y2K2 | U4-theraphotoxin-Hhn1s | 7.33e-03 | 8.82e-03 | NA |
2. P | Q9GLD0 | Natriuretic peptides A | 1.62e-02 | 1.26e-06 | NA |
2. P | P08435 | Tachykinin-3 | 1.68e-02 | 1.03e-04 | NA |
2. P | Q9PUR0 | Glucagon-2 | 1.72e-04 | 1.54e-02 | NA |
2. P | P0DKU5 | Apolipoprotein C-II | 6.78e-03 | 4.74e-03 | NA |
2. P | P10082 | Peptide YY | 3.73e-03 | 1.42e-07 | NA |
2. P | Q9BT56 | Spexin | 2.36e-02 | 6.18e-03 | NA |
2. P | P60042 | Somatostatin | 1.12e-02 | 1.04e-06 | NA |
2. P | Q9VLK4 | Diuretic hormone class 2 | 1.71e-03 | 1.09e-10 | NA |
2. P | P0CV00 | Secreted RxLR effector protein 21 | 5.11e-03 | 6.16e-11 | NA |
2. P | Q8WSV2 | Andropin | 3.74e-04 | 1.37e-02 | NA |
2. P | L0GBQ6 | Antimicrobial peptide Con22 | 4.95e-02 | 3.70e-02 | NA |
2. P | D2Y227 | U4-theraphotoxin-Hhn1h | 6.43e-03 | 1.46e-02 | NA |
2. P | P33439 | Progonadoliberin-1 | 1.68e-02 | 2.33e-02 | NA |
2. P | P08948 | [Leu8]-phyllolitorin | 7.93e-03 | 9.58e-05 | NA |
2. P | P0DPG8 | Apolipoprotein C-I | 1.37e-03 | 8.95e-04 | NA |
2. P | C0HKT2 | Pro-corazonin | 6.44e-03 | 2.10e-03 | NA |
2. P | P21663 | Andropin | 6.11e-03 | 2.47e-02 | NA |
2. P | Q9XVX1 | FMRFamide-like neuropeptides 19 | 3.14e-04 | 2.07e-04 | NA |
2. P | P08494 | Matrix Gla protein | 2.20e-02 | 4.54e-04 | NA |
2. P | P06580 | Prepro-urotensin II-gamma | 1.22e-02 | 6.80e-05 | NA |
2. P | Q9I8P3 | Pro-neuropeptide Y | 8.18e-03 | 1.26e-05 | NA |
2. P | P04640 | Osteocalcin | 1.89e-02 | 4.33e-12 | NA |
2. P | P07499 | Natriuretic peptides A | 1.19e-02 | 9.86e-05 | NA |
2. P | P83965 | Brain natriuretic peptide | 3.30e-03 | 3.15e-12 | NA |
2. P | Q5G859 | Defensin-7 | 1.64e-02 | 2.16e-03 | NA |
2. P | P0DKW1 | Apolipoprotein C-IV | 5.19e-04 | 3.14e-03 | NA |
2. P | Q8L8Y3 | Precursor of CEP1 | 1.16e-01 | 8.60e-03 | NA |
2. P | P08858 | Tachykinin-3 | 1.19e-02 | 5.65e-04 | NA |
2. P | D2Y2H2 | Hainantoxin-XVIII-4 | 2.05e-01 | 1.34e-02 | NA |
2. P | G4MM89 | Host transcription reprogramming factor 4 | 3.61e-01 | 2.83e-02 | NA |
2. P | D2Y2D5 | U4-theraphotoxin-Hhn1a | 4.50e-02 | 3.15e-02 | NA |
2. P | P36192 | Defensin | 7.55e-02 | 3.25e-03 | NA |
2. P | A0A5J6K6K4 | N.vectensis toxin 4 | NA | 3.55e-02 | NA |
2. P | P18658 | Apolipoprotein C-II | 3.91e-03 | 1.48e-03 | NA |
2. P | O18641 | PBAN-type neuropeptides | 4.53e-02 | 2.03e-03 | NA |
2. P | P05366 | Serum amyloid A-1 protein | 6.85e-03 | 3.36e-03 | NA |
2. P | P84225 | Cecropin-C | 1.16e-02 | 5.88e-03 | NA |
2. P | P01356 | Cholecystokinin | 7.99e-04 | 6.37e-06 | NA |
2. P | D2Y208 | U4-theraphotoxin-Hhn1a | 5.55e-03 | 3.79e-02 | NA |
2. P | Q8WSV4 | Andropin | 5.08e-04 | 1.99e-02 | NA |
2. P | P56595 | Apolipoprotein C-I | 1.34e-03 | 6.83e-04 | NA |
2. P | P0DMP0 | Apolipoprotein C-I | 1.11e-02 | 1.99e-02 | NA |
2. P | D2Y231 | U4-theraphotoxin-Hhn1b | 1.96e-02 | 8.53e-03 | NA |
2. P | P81602 | Defensin-B | 3.21e-02 | 3.44e-02 | NA |
2. P | B3FIN4 | U7-theraphotoxin-Hs1a | 6.79e-02 | 9.13e-03 | NA |
2. P | Q9YGH3 | Somatostatin-1B | 1.74e-03 | 1.97e-06 | NA |
2. P | Q52MQ7 | Keratinocyte differentiation-associated protein | 3.11e-02 | 6.00e-05 | NA |
2. P | O57312 | Cholecystokinin | 7.49e-03 | 7.26e-06 | NA |
2. P | D2Y223 | U4-theraphotoxin-Hhn1d | 2.07e-05 | 1.37e-02 | NA |
2. P | F8J4S0 | Oxyopinin-4a | 2.52e-03 | 1.56e-02 | NA |
2. P | P13304 | Antiholin | NA | 1.91e-02 | NA |
2. P | Q8WTD4 | Defensin-A | 1.17e-01 | 9.05e-03 | NA |
2. P | Q8S8N0 | CLAVATA3/ESR (CLE)-related protein 4 | 6.43e-03 | 1.85e-05 | NA |
2. P | P02820 | Osteocalcin | 1.83e-02 | 1.22e-07 | NA |
2. P | Q4QXT8 | Neuromedin-S | 9.28e-03 | 2.21e-04 | NA |
2. P | A0A172M418 | Secreted RxLR effector protein 2 | 7.81e-05 | 1.75e-02 | NA |
2. P | P10631 | Peptide YY | 7.25e-02 | 3.12e-04 | NA |
2. P | Q9MZR8 | Interleukin-4 | 1.17e-02 | 3.28e-02 | NA |
2. P | P01581 | Interferon gamma | 2.18e-02 | 2.01e-02 | NA |
2. P | Q9PTS1 | Corticoliberin | 4.96e-03 | 8.90e-03 | NA |
2. P | Q805D8 | Natriuretic peptides A | 8.78e-03 | 1.11e-04 | NA |
2. P | Q27023 | Tenecin-1 | 7.31e-02 | 4.42e-04 | NA |
2. P | D0N0J7 | RxLR effector protein SFI1 | 2.60e-02 | 3.06e-03 | NA |
2. P | P13438 | Trophoblast-specific protein alpha | 6.18e-03 | 1.30e-07 | NA |
2. P | Q3V3I5 | Uncharacterized protein C17orf67 homolog | 2.73e-03 | 1.66e-03 | NA |
2. P | Q92106 | Progonadoliberin-3 | 6.44e-02 | 1.86e-03 | NA |
2. P | Q9XSN5 | Apolipoprotein C-I | 2.07e-03 | 1.84e-03 | NA |
2. P | D2Y2N9 | Hainantoxin-XVIII-5 | 2.51e-01 | 6.96e-03 | NA |
2. P | P0DM84 | Apolipoprotein C-I | 2.83e-03 | 1.99e-02 | NA |
2. P | P0DJI8 | Serum amyloid A-1 protein | 7.64e-03 | 2.64e-03 | NA |
2. P | P30123 | Interferon gamma | 7.81e-03 | 8.31e-05 | NA |
2. P | Q9IA08 | Progonadoliberin-2 | 1.25e-02 | 3.87e-07 | NA |
2. P | Q70KL2 | Beta-defensin 40 | 3.76e-02 | 3.36e-02 | NA |
2. P | O97386 | Crustacean hyperglycemic hormones 4 | 7.19e-02 | 2.63e-02 | NA |
2. P | H9FNA4 | Apolipoprotein C-I, basic form | 8.71e-03 | 1.10e-05 | NA |
2. P | O46540 | Natriuretic peptides A | 1.90e-02 | 1.46e-05 | NA |
2. P | P01268 | Parathyroid hormone | 5.63e-03 | 2.63e-09 | NA |
2. P | P12760 | Neuromedin-U | 1.03e-01 | 4.95e-05 | NA |
2. P | P84019 | Cecropin-C | 2.49e-04 | 2.83e-03 | NA |
2. P | A0AEI6 | Brevinin-2GHc | 3.00e-04 | 3.86e-03 | NA |
2. P | Q9BJW0 | Omega-hexatoxin-Hi2b | 1.19e-02 | 4.10e-03 | NA |
2. P | A0A072TRR8 | CLAVATA3/ESR (CLE)-related protein 53 | 4.69e-03 | 4.39e-03 | NA |
2. P | O16825 | Andropin | 2.29e-02 | 2.93e-02 | NA |
2. P | P01355 | Cholecystokinin | 5.15e-03 | 4.59e-02 | NA |
2. P | D2Y251 | Hainantoxin-XVIII | 2.74e-01 | 1.12e-02 | NA |
2. P | D2Y2J4 | U4-theraphotoxin-Hhn1m | 3.39e-02 | 2.88e-02 | NA |
2. P | P61278 | Somatostatin | 2.06e-02 | 1.66e-05 | NA |
2. P | A0A072V9Z0 | CLAVATA3/ESR (CLE)-related protein 33 | 2.55e-03 | 9.37e-04 | NA |
2. P | P0DKU7 | Apolipoprotein C-I, acidic form | 5.53e-02 | 4.58e-03 | NA |
2. P | P0DKY1 | Apolipoprotein C-II | 2.29e-03 | 7.41e-04 | NA |
2. P | Q9XSE2 | Promotilin | 2.31e-03 | 3.57e-03 | NA |
2. P | O93225 | Dermaseptin AA-3-4 | 3.12e-04 | 1.18e-02 | NA |
2. P | Q8MP00 | Neuropeptide F | 7.52e-03 | 4.31e-02 | NA |
2. P | A0A5P9K9Z4 | Dermaseptin-SP3 | 3.37e-05 | 7.20e-05 | NA |
2. P | Q5CCK0 | Interferon gamma | 9.22e-03 | 9.22e-05 | NA |
2. P | Q27441 | Pro-neuropeptide Y | 7.95e-03 | 1.01e-02 | NA |
2. P | Q45VN2 | Alpha-defensin 20 | 2.09e-01 | 6.41e-04 | NA |
2. P | P63292 | Somatoliberin | 2.06e-03 | 9.12e-04 | NA |
2. P | P24259 | Natriuretic peptides A | 2.30e-02 | 2.94e-06 | NA |
2. P | D2Y2D6 | U4-theraphotoxin-Hhn1a | 7.16e-03 | 3.22e-03 | NA |
2. P | Q9HDT7 | UPF0321 protein P20C8.02c | 9.26e-02 | 1.42e-03 | NA |
2. P | P0CJ11 | Venom protein 55.1 | 1.28e-02 | 5.04e-03 | NA |
2. P | Q9Z2R5 | Apolipoprotein C-III | 1.20e-02 | 7.62e-04 | NA |
2. P | P81485 | Dermaseptin-B3 | 5.74e-04 | 1.37e-03 | NA |
2. P | A0A5P9K5G4 | Dermaseptin-SP5 | 3.53e-04 | 2.34e-05 | NA |
2. P | P50144 | Cholecystokinin A | 2.49e-02 | 8.64e-04 | NA |
2. P | P22977 | Chorion protein S16 | 1.53e-02 | 1.21e-02 | NA |
2. P | Q8UW80 | Progonadoliberin-1 | 7.51e-03 | 9.20e-04 | NA |
2. P | P0DM96 | Apolipoprotein A-II | 7.66e-04 | 4.74e-03 | NA |
2. P | P84021 | Cecropin-C | 4.92e-04 | 2.83e-03 | NA |
2. P | P0DTR1 | Apolipoprotein A-II | 3.14e-03 | 5.63e-03 | NA |
2. P | B1P1A8 | U3-theraphotoxin-Cg1b | 1.45e-02 | 3.20e-02 | NA |
2. P | Q1JS94 | Palustrin-1c | 4.16e-04 | 4.90e-02 | NA |
2. P | Q9TT95 | Galanin-like peptide | 4.00e-02 | 2.98e-03 | NA |
2. P | P28309 | Alpha-defensin 2 | 4.55e-01 | 1.08e-03 | NA |
2. P | P51918 | Progonadoliberin-1 | 7.30e-03 | 1.35e-05 | NA |
2. P | P09859 | Gastrin/cholecystokinin-like peptide | 2.71e-03 | 6.06e-08 | NA |
2. P | P86038 | Raniseptin-3 | 3.04e-04 | 4.82e-02 | NA |
2. P | Q25BC0 | Interferon gamma | 1.73e-02 | 1.86e-03 | NA |
2. P | P06759 | Apolipoprotein C-III | 1.17e-03 | 2.02e-05 | NA |
2. P | Q6RUW3 | Pro-neuropeptide Y | 2.30e-02 | 6.11e-06 | NA |
2. P | Q90Y63 | Progonadoliberin-1 | 1.06e-03 | 7.89e-04 | NA |
2. P | D2Y241 | U3-theraphotoxin-Hhn1a 2 | 1.43e-01 | 1.70e-02 | NA |
2. P | Q9H1Z8 | Augurin | 3.06e-02 | 5.61e-07 | NA |
2. P | A0A193H397 | Cruzioseptin-12 | 5.66e-05 | 4.95e-05 | NA |
2. P | Q9DG36 | Progonadoliberin-2 | 1.40e-03 | 2.57e-08 | NA |
2. P | P02782 | Prostatic steroid-binding protein C1 | 5.00e-02 | 5.58e-06 | NA |
2. P | D2Y2K6 | U4-theraphotoxin-Hhn1a | 3.76e-03 | 1.84e-03 | NA |
2. P | D2Y215 | U4-theraphotoxin-Hhn1x | 5.89e-02 | 4.62e-03 | NA |
2. P | P14765 | Pro-neuropeptide Y | 1.91e-02 | 9.14e-06 | NA |
2. P | P83228 | Natriuretic peptide TNP-b | 2.08e-01 | 2.33e-08 | NA |
2. P | Q5H8A1 | Neuromedin-S | 5.57e-02 | 6.82e-10 | NA |
2. P | P01299 | Pancreatic prohormone | 6.84e-03 | 2.32e-05 | NA |
2. P | Q86MA1 | Moricin | 1.32e-03 | 3.00e-03 | NA |
2. P | P28310 | Alpha-defensin 3 | 2.95e-01 | 2.33e-03 | NA |
2. P | P11384 | Secretin | 1.07e-02 | 2.11e-10 | NA |
2. P | P61849 | Dromyosuppressin | 1.69e-03 | 5.88e-03 | NA |
2. P | P81686 | Cecropin-B | 1.26e-02 | 9.28e-03 | NA |
2. P | P69031 | Aurein-5.2 | 1.79e-03 | 1.99e-02 | NA |
2. P | P14956 | Cecropin-B | 2.47e-04 | 1.40e-02 | NA |
2. P | P08376 | Sarcotoxin-1B | 1.14e-02 | 4.82e-02 | NA |
2. P | P0DQF7 | U-scoloptoxin(23)-Er1a | 1.41e-03 | 1.30e-02 | NA |
2. P | P0CV69 | Secreted RxLR effector protein 158 | 3.76e-02 | 1.19e-02 | NA |
2. P | Q9BHA6 | Conotoxin Ar5.1 a | 1.85e-02 | 4.56e-02 | NA |
2. P | Q3V2D2 | Uncharacterized protein C5orf46 homolog | 3.93e-03 | 1.49e-04 | NA |
2. P | P50714 | Alpha-defensin 16 | 3.71e-01 | 1.20e-04 | NA |
2. P | P01364 | Abdominal ganglion neuropeptide R3-14 | 2.13e-03 | 7.04e-06 | NA |
2. P | G4MRT1 | Host transcription reprogramming factor 3 | 5.05e-02 | 1.88e-02 | NA |
2. P | P17773 | Interferon gamma | 4.27e-03 | 1.37e-03 | NA |
2. P | P48749 | Granulocyte-macrophage colony-stimulating factor | 2.86e-02 | 3.33e-03 | NA |
2. P | A0A088MI62 | [Val1,Thr6]-bradykinyl-Val,Asp | 1.60e-02 | 2.33e-02 | NA |
2. P | P05011 | Interferon alpha-1 | 1.07e-02 | 2.47e-02 | NA |
2. P | Q8QGA2 | Tuberoinfundibular peptide of 39 residues | 1.42e-03 | 3.87e-07 | NA |
2. P | P0DP87 | Apolipoprotein A-II | 1.52e-03 | 4.32e-03 | NA |
2. P | P54230 | Cathelicidin-1 | 3.86e-02 | 1.23e-02 | NA |
2. P | Q9XZH0 | Cecropin-B (Fragment) | 2.50e-02 | 5.05e-05 | NA |
2. P | P09916 | Somatoliberin | 2.22e-03 | 7.34e-09 | NA |
2. P | Q1WM28 | Interferon gamma | NA | 2.87e-04 | NA |
2. P | O93224 | Dermaseptin-A4 | 1.07e-03 | 2.61e-02 | NA |
2. P | O46688 | Somatostatin | 1.83e-02 | 2.88e-06 | NA |
2. P | Q62715 | Neutrophil antibiotic peptide NP-2 | 4.07e-02 | 4.59e-02 | NA |
2. P | A0A348G5V9 | U-poneritoxin(01)-Om3a | 1.94e-03 | 4.90e-02 | NA |
2. P | Q9QXQ6 | Galanin-like peptide | 2.88e-02 | 9.88e-04 | NA |
2. P | P37085 | Pigment-dispersing hormone A peptides | 4.04e-03 | 3.36e-06 | NA |
2. P | Q5DW47 | Pro-corazonin | 8.48e-02 | 6.68e-03 | NA |
2. P | P0DMT9 | Apolipoprotein C-II | 5.08e-02 | 6.54e-05 | NA |
2. P | P24511 | Chorion protein S16 | 2.19e-02 | 2.49e-08 | NA |
2. P | P01286 | Somatoliberin | 2.33e-03 | 4.26e-07 | NA |
2. P | P23362 | Cholecystokinin | 1.22e-03 | 6.18e-05 | NA |
2. P | P01171 | Somatostatin-1 | 1.20e-02 | 4.12e-07 | NA |
2. P | P84226 | Cecropin-C | 1.71e-04 | 5.88e-03 | NA |
2. P | P0C9H1 | Protein MGF 110-4L | NA | 9.13e-03 | NA |
2. P | P14200 | Pro-MCH | 1.15e-02 | 1.98e-04 | NA |
2. P | P0DP52 | Apolipoprotein C-II | 3.95e-04 | 1.36e-02 | NA |
2. P | P0DUP5 | Apolipoprotein C-IV | 4.16e-03 | 1.49e-02 | NA |
2. P | C0HK03 | Ocellatin-PT8 | 1.97e-04 | 1.25e-04 | NA |
2. P | P51919 | Progonadoliberin-1 | 2.91e-02 | 1.12e-06 | NA |
2. P | Q5G865 | Alpha-defensin 24 | 1.99e-01 | 4.62e-03 | NA |
2. P | A0A023VZF1 | U-scoloptoxin(04)-Er1f (Fragment) | 8.20e-01 | 3.70e-03 | NA |
2. P | Q8AXR2 | C-type natriuretic peptide 2 | 3.15e-02 | 4.04e-07 | NA |
2. P | P31532 | Serum amyloid A-4 protein | 2.45e-02 | 3.55e-02 | NA |
2. P | D5J9S0 | Natriuretic peptide BF131 | 3.23e-02 | 8.56e-04 | NA |
2. P | D2Y222 | U4-theraphotoxin-Hhn1y | 2.47e-06 | 2.61e-02 | NA |
2. P | P13589 | Pituitary adenylate cyclase-activating polypeptide | 4.52e-03 | 1.76e-02 | NA |
2. P | P33689 | Pro-neuropeptide Y | 3.43e-03 | 9.10e-08 | NA |
2. P | P83403 | Cecropin | 1.21e-02 | 3.58e-02 | NA |
2. P | P0DP85 | Apolipoprotein A-II | 1.32e-03 | 4.32e-03 | NA |
2. P | E2AZE8 | Diuretic hormone class 2 | 8.49e-03 | 1.12e-11 | NA |
2. P | P22226 | Cathelicidin-1 | 5.98e-02 | 2.31e-02 | NA |
2. P | P13684 | Prolevitide | 3.87e-03 | 2.66e-07 | NA |
2. P | Q27IM2 | Parathyroid hormone | 4.20e-03 | 7.15e-08 | NA |
2. P | P81644 | Apolipoprotein A-II | 2.90e-03 | 2.97e-02 | NA |
2. P | P0DN54 | Teretoxin Tsu6.5 | 2.49e-01 | 7.45e-03 | NA |
2. P | D2Y2K5 | U4-theraphotoxin-Hhn1a | 9.55e-03 | 1.02e-02 | NA |
2. P | P50705 | Alpha-defensin 7 | 3.56e-01 | 4.93e-04 | NA |
2. P | Q06202 | Pigment-dispersing hormone peptides | 5.60e-03 | 1.86e-03 | NA |
2. P | P47851 | Gastrin-releasing peptide | 1.40e-02 | 1.39e-05 | NA |
2. P | P0DPH1 | Apolipoprotein C-I | 1.05e-02 | 3.88e-02 | NA |
2. P | O49519 | CLAVATA3/ESR (CLE)-related protein 2 | 1.28e-01 | 6.34e-03 | NA |
2. P | Q765I2 | Urotensin-2B | 1.60e-03 | 3.05e-05 | NA |
2. P | P30973 | Progonadoliberin-3 | 2.30e-02 | 2.06e-02 | NA |
2. P | O42413 | Matrix Gla protein | 1.74e-02 | 3.74e-05 | NA |
2. P | O76146 | Cecropin-D | 7.33e-03 | 1.24e-02 | NA |
2. P | Q9PT99 | Peptide YY-like | 2.91e-03 | 1.60e-07 | NA |
2. P | P49670 | Somatostatin | 2.24e-02 | 1.21e-06 | NA |
2. P | P0DPG9 | Apolipoprotein C-I | 1.61e-03 | 2.39e-03 | NA |
2. P | P61279 | Somatostatin | 9.22e-03 | 1.66e-05 | NA |
2. P | Q5H8A2 | Neuromedin-S | 1.31e-01 | 7.29e-12 | NA |
2. P | P0C8A9 | Defensin-B5 | 2.67e-01 | 3.94e-02 | NA |
2. P | Q9PTQ4 | UI | 1.33e-03 | 3.09e-06 | NA |
2. P | Q5I6S9 | Interferon gamma | 7.87e-03 | 9.44e-03 | NA |
2. P | D2Y207 | U4-theraphotoxin-Hhn1a | 2.67e-06 | 4.67e-02 | NA |
2. P | D2Y2J6 | U4-theraphotoxin-Hhn1o | 2.69e-02 | 3.41e-02 | NA |
2. P | D5KXH2 | Turripeptide IX-04 | 2.73e-01 | 4.14e-03 | NA |
2. P | Q90WF4 | Pro-neuropeptide Y | 3.24e-03 | 1.82e-04 | NA |
2. P | P48144 | Glucagon family neuropeptides | 5.11e-03 | 1.88e-07 | NA |
2. P | Q28HK1 | Unique cartilage matrix-associated protein | 3.38e-04 | 2.70e-02 | NA |
2. P | Q9W7F0 | Somatostatin-1 | 3.03e-02 | 1.44e-05 | NA |
2. P | Q23971 | Antennal-specific protein OS-C | 4.68e-02 | 2.61e-04 | NA |
2. P | D2Y2G7 | U3-theraphotoxin-Hhn1n | 9.40e-02 | 4.17e-02 | NA |
2. P | P83964 | Natriuretic peptides A | 1.08e-02 | 1.00e-02 | NA |
2. P | B4I608 | Protein Turandot F | 9.87e-03 | 2.27e-02 | NA |
2. P | Q9W7E9 | Somatostatin-2 | 2.61e-03 | 1.93e-06 | NA |
2. P | P0DMT8 | Apolipoprotein C-I | 7.42e-03 | 4.03e-03 | NA |
2. P | P01508 | Cecropin-B | 1.58e-02 | 1.56e-02 | NA |
2. P | Q76CL2 | Peptide YY | 7.40e-03 | 1.00e-06 | NA |
2. P | P37044 | Progonadoliberin-2 | 5.15e-03 | 9.05e-06 | NA |
2. P | P01160 | Natriuretic peptides A | 2.17e-02 | 5.00e-05 | NA |
2. P | P0DJI9 | Serum amyloid A-2 protein | 7.90e-03 | 9.86e-05 | NA |
2. P | P0DKW2 | Apolipoprotein C-IV | 8.29e-04 | 1.77e-04 | NA |
2. P | P33740 | Accessory gland-specific peptide 26Ab | 9.00e-02 | 1.04e-06 | NA |
2. P | Q90WP7 | Peptide leucine arginine | 3.23e-02 | 1.09e-02 | NA |
2. P | Q5I4E6 | Conotoxin Gla-TxX | 1.14e-02 | 8.88e-05 | NA |
2. P | P0DPY4 | U-scoloptoxin(10)-Sm1a | 2.34e-02 | 4.21e-03 | NA |
2. P | P34928 | Apolipoprotein C-I | 2.68e-03 | 1.62e-02 | NA |
2. P | P0DTG8 | Apolipoprotein C-I | 1.54e-02 | 4.37e-05 | NA |
2. P | P0DPH2 | Apolipoprotein C-I | 1.18e-03 | 1.13e-03 | NA |
2. P | Q8CE23 | Orexigenic neuropeptide QRFP | 8.21e-02 | 3.50e-02 | NA |
2. P | P40753 | Natriuretic peptides B | 2.09e-03 | 5.48e-13 | NA |
2. P | P01301 | Pancreatic prohormone (Fragment) | 7.80e-02 | 5.61e-08 | NA |
2. P | P69157 | Pro-MCH 2 | 2.20e-01 | 1.70e-02 | NA |
2. P | Q9M2Y0 | Phytosulfokines 3 | 5.93e-03 | 2.18e-08 | NA |
2. P | P18908 | Natriuretic peptides A | 1.16e-02 | 7.07e-08 | NA |
2. P | Q6UXT8 | ALK and LTK ligand 1 | 1.33e-01 | 3.54e-03 | NA |
2. P | P0DTT3 | Apolipoprotein C-I | 1.70e-03 | 4.62e-04 | NA |
2. P | D2Y2K3 | U4-theraphotoxin-Hhn1t | 7.36e-03 | 4.14e-02 | NA |
2. P | D2Y2J5 | U4-theraphotoxin-Hhn1n | 2.64e-02 | 4.38e-02 | NA |
2. P | D2Y206 | U4-theraphotoxin-Hhn1a | 9.26e-03 | 1.09e-02 | NA |
2. P | P0DOA2 | Apolipoprotein C-I, basic form | 1.11e-03 | 1.10e-05 | NA |
2. P | P0DTT5 | Apolipoprotein C-I | 1.38e-02 | 1.78e-04 | NA |
2. P | Q9VG55 | Protein hugin | 1.12e-03 | 1.44e-03 | NA |
2. P | Q3EDH8 | CLAVATA3/ESR (CLE)-related protein 3 | 3.87e-04 | 2.38e-04 | NA |
2. P | Q1HA20 | Neuromedin-S | 3.33e-02 | 8.12e-07 | NA |
2. P | A0A2Y9GES1 | Apolipoprotein A-II | 1.17e-02 | 5.78e-03 | NA |
2. P | P61103 | Mu-theraphotoxin-Hs1a | 8.06e-02 | 1.69e-02 | NA |
2. P | P19788 | Matrix Gla protein | 9.15e-03 | 3.99e-04 | NA |
2. P | P47939 | Regulated endocrine-specific protein 18 | 1.64e-02 | 4.41e-02 | NA |
2. P | C0HK01 | Ocellatin-PT6 | 4.68e-03 | 3.38e-04 | NA |
2. P | P61366 | Osteocrin | 2.33e-02 | 4.56e-02 | NA |
2. P | P13204 | Natriuretic peptides B | 2.16e-03 | 3.41e-10 | NA |
2. P | Q06435 | Interleukin-3 | 4.13e-02 | 1.49e-04 | NA |
2. P | P41319 | C-type natriuretic peptide | 2.00e-02 | 2.44e-06 | NA |
2. P | P0DTQ8 | Apolipoprotein C-I | 4.07e-03 | 5.70e-04 | NA |
2. P | P55885 | Gastrin | 9.35e-02 | 2.11e-02 | NA |
2. P | P50708 | Alpha-defensin 10 | 2.58e-01 | 1.67e-04 | NA |
2. P | Q9VU58 | Neuropeptide-like 2 | 2.02e-02 | 3.00e-04 | NA |
2. P | P0CV07 | Secreted RxLR effector protein 38 | 6.42e-03 | 2.09e-02 | NA |
2. P | Q9GL67 | Parathyroid hormone | 3.02e-03 | 1.93e-06 | NA |
2. P | P79154 | Interferon gamma | 3.96e-03 | 3.67e-03 | NA |
2. P | P01302 | Pancreatic prohormone | 2.99e-02 | 1.23e-05 | NA |
2. P | P81941 | Pleurocidin | 1.34e-04 | 9.05e-03 | NA |
2. P | Q9QYH7 | Appetite-regulating hormone | 1.28e-02 | 8.00e-05 | NA |
2. P | Q9TV67 | Interferon gamma | 6.10e-03 | 4.54e-04 | NA |
2. P | P23233 | Nodulin-16 | 5.91e-02 | 1.14e-03 | NA |
2. P | P19035 | Apolipoprotein C-III | 6.50e-03 | 5.49e-03 | NA |
2. P | G7NYP9 | Osteocrin | 2.76e-02 | 2.29e-02 | NA |
2. P | M9P2C1 | Tachykinin-like peptide | 6.96e-03 | 4.71e-04 | NA |
2. P | D2Y252 | Hainantoxin-XVIII-2 | 1.63e-01 | 3.33e-02 | NA |
2. P | O77620 | Interleukin-2 | 2.63e-02 | 2.15e-02 | NA |
2. P | P0DPG0 | Apolipoprotein C-I, acidic form | 2.94e-03 | 2.88e-02 | NA |
2. P | Q4ZH68 | Interferon gamma | 1.79e-02 | 8.68e-03 | NA |
2. P | Q8MPY9 | FMRFamide-like neuropeptides 26 | 2.54e-02 | 1.33e-05 | NA |
2. P | P79799 | Natriuretic peptide Mc-NP | 2.34e-01 | 1.53e-03 | NA |
2. P | Q8MMH4 | Small venom protein 2 | 6.91e-03 | 2.69e-04 | NA |
2. P | D2Y2K4 | U4-theraphotoxin-Hhn1u | 2.99e-06 | 3.91e-02 | NA |
2. P | Q9AR88 | Phytosulfokines 4 | 5.68e-03 | 9.79e-04 | NA |
2. P | P0DUQ8 | Conotoxin Pl064 | NA | 3.94e-02 | NA |
2. P | Q11099 | Protein snet-1 | 1.05e-03 | 2.14e-03 | NA |
2. P | P23227 | Developmentally-regulated ectodermal protein | 1.45e-02 | 1.80e-05 | NA |
2. P | P0DTQ7 | Apolipoprotein C-I | 2.77e-03 | 3.17e-04 | NA |
2. P | W4VSI8 | Toxin ICK-8 | 1.40e-02 | 9.12e-04 | NA |
2. P | Q865X1 | Interferon gamma | 8.03e-03 | 3.57e-03 | NA |
2. P | D0P1B2 | RxLR effector protein SFI8 | 7.82e-02 | 2.93e-02 | NA |
2. P | P40147 | Osteocalcin | 1.85e-02 | 3.82e-02 | NA |
2. P | P11242 | Galanin peptides | 1.52e-02 | 7.85e-05 | NA |
2. P | Q9BDX4 | Interleukin-3 | 9.74e-03 | 1.71e-09 | NA |
2. P | P86442 | Neuropeptide F | 6.59e-03 | 1.14e-06 | NA |
2. P | P0DN96 | Precursor of CEP7 | 3.73e-02 | 2.46e-03 | NA |
2. P | B6HY16 | Dermaseptin-related peptide | 3.45e-04 | 4.03e-03 | NA |
2. P | P18419 | Seminal vesicle secretory protein 4 | 1.26e-01 | 4.14e-03 | NA |
2. P | P46402 | Interferon gamma | 8.26e-03 | 2.03e-04 | NA |
2. P | P01510 | Cecropin-D | 6.43e-03 | 3.50e-02 | NA |
2. P | Q800R4 | Plasticin-B1 | 2.98e-03 | 3.25e-02 | NA |
2. P | W4VSI5 | Toxin ICK-23 | 3.37e-03 | 1.69e-02 | NA |
2. P | P29007 | Gastrin-releasing peptide | 2.22e-03 | 5.26e-03 | NA |
2. P | A0A0P1AXF0 | Secreted RxLR effector protein RXLR-C06 | 2.31e-03 | 2.08e-03 | NA |
2. P | P87384 | Somatostatin-1 | 6.62e-03 | 1.74e-08 | NA |
2. P | Q3V2T4 | Keratinocyte differentiation-associated protein | 5.23e-02 | 5.50e-05 | NA |
2. P | D2Y2L3 | U4-theraphotoxin-Hhn1a | 1.91e-02 | 1.40e-02 | NA |
2. P | P28673 | Pro-neuropeptide Y | 1.50e-02 | 2.21e-05 | NA |
2. P | Q9YGH5 | Somatostatin-1A | 4.07e-03 | 6.47e-08 | NA |
2. P | P50721 | Hyphancin-3E | 1.83e-02 | 8.75e-03 | NA |
2. P | B3FIS6 | U5-theraphotoxin-Hs1b 1 | 1.83e-01 | 3.20e-02 | NA |
2. P | O77762 | Interleukin-4 | 9.17e-03 | 3.15e-02 | NA |
2. P | P05367 | Serum amyloid A-2 protein | 9.92e-03 | 1.70e-03 | NA |
2. P | P19034 | Apolipoprotein C-II | 8.31e-04 | 1.85e-02 | NA |
2. P | P55030 | Interleukin-4 | 5.32e-03 | 9.60e-03 | NA |
2. P | P08493 | Matrix Gla protein | 1.05e-02 | 9.05e-05 | NA |
2. P | W4VSB9 | Toxin ICK-9 | 9.31e-03 | 4.55e-03 | NA |
2. P | P0DKU6 | Apolipoprotein C-IV | 9.41e-04 | 5.70e-04 | NA |
2. P | E2A6P1 | Diuretic hormone 44 | 3.49e-03 | 2.09e-02 | NA |
2. P | P0CV70 | Secreted RxLR effector protein 159 | 2.10e-02 | 4.90e-02 | NA |
2. P | P0DM95 | Apolipoprotein A-II | 1.55e-03 | 1.11e-03 | NA |
2. P | P52212 | Parathyroid hormone | 5.72e-04 | 1.68e-05 | NA |
2. P | Q18184 | FMRFamide-like neuropeptides 27 | 3.23e-02 | 4.41e-05 | NA |
2. P | D0N0Z8 | RxLR effector protein PexRD24 | 1.83e-01 | 9.68e-03 | NA |
2. P | P09240 | Cholecystokinin | 2.22e-03 | 3.39e-03 | NA |
2. P | Q75WG7 | U13-hexatoxin-Mg1a | 2.68e-02 | 1.14e-02 | NA |
2. P | Q09352 | Uncharacterized protein T10B9.29 | 2.73e-02 | 2.27e-06 | NA |
2. P | D0NB60 | RxLR effector protein PITG_09218 | 1.77e-02 | 4.56e-02 | NA |
2. P | P53613 | Serum amyloid A protein | 2.51e-02 | 4.63e-02 | NA |
2. P | Q1ELU1 | M-zodatoxin-Lt2a | 6.05e-02 | 3.85e-02 | NA |
2. P | Q9JI02 | Secretoglobin family 2B member 20 | 2.03e-02 | 3.70e-03 | NA |
2. P | Q6PDA7 | Sperm-associated antigen 11A | 4.23e-01 | 5.25e-10 | NA |
2. P | B4PPU6 | Protein Turandot Z | 9.87e-03 | 1.11e-02 | NA |
2. P | P14665 | Bactericidin B-5P | 3.62e-03 | 1.68e-03 | NA |
2. P | P10683 | Galanin peptides | 2.27e-01 | 7.00e-05 | NA |
2. P | P0DPY5 | U-scoloptoxin(10)-Sm2a | 1.99e-02 | 1.15e-02 | NA |
2. P | P0DTS4 | Apolipoprotein C-III | 7.99e-03 | 1.90e-02 | NA |
2. P | A0A096P2H7 | Apolipoprotein C-I, basic form | 9.85e-04 | 3.67e-05 | NA |
2. P | Q0MWV8 | Antimicrobial peptide aurelin | 4.79e-02 | 3.12e-02 | NA |
2. P | D2Y2D4 | U4-theraphotoxin-Hhn1i | 8.54e-03 | 2.35e-02 | NA |
2. P | Q9BEF8 | Appetite-regulating hormone | 1.96e-03 | 1.19e-04 | NA |
2. P | P0DPH4 | Apolipoprotein C-I | 2.99e-03 | 1.06e-04 | NA |
2. P | P02783 | Seminal vesicle secretory protein 4 | 1.10e-01 | 3.19e-03 | NA |
2. P | O96690 | Protein PDF | 3.20e-02 | 2.23e-08 | NA |
2. P | O81003 | Phytosulfokines 2 | 7.12e-02 | 1.28e-05 | NA |
2. P | B3NKZ6 | Protein Turandot E | 7.46e-03 | 2.29e-02 | NA |
2. P | Q4JEI2 | Defensin alpha-like protein 1 | 1.62e-01 | 2.53e-02 | NA |
2. P | P0DMR2 | Secretoglobin family 1C member 2 | 7.91e-03 | 1.62e-02 | NA |
2. P | P0CJ15 | Venom protein 3.1 | 6.56e-03 | 5.39e-03 | NA |
2. P | P0DJK1 | Sarafotoxin-i2 | 2.52e-01 | 1.37e-02 | NA |
2. P | D2Z1D6 | Pigment-dispersing hormone peptides | 1.81e-02 | 6.90e-04 | NA |
2. P | Q8WSV0 | Andropin | 9.05e-03 | 1.94e-03 | NA |
2. P | W4VRV2 | Toxin ICK-11 | 2.32e-02 | 2.19e-03 | NA |
2. P | Q2UXR1 | Lividin-4 | 1.54e-04 | 3.17e-02 | NA |
2. P | Q9XS58 | Interleukin-4 | 7.09e-03 | 4.43e-03 | NA |
2. P | O00230 | Cortistatin | 6.92e-03 | 1.68e-02 | NA |
2. P | Q00676 | Bradykinin-like neuropeptide | 4.33e-02 | 5.36e-06 | NA |
2. P | P55056 | Apolipoprotein C-IV | 4.55e-04 | 1.44e-02 | NA |
2. P | Q86C49 | U1-theraphotoxin-Hs1f | 3.54e-03 | 3.70e-02 | NA |
2. P | N0EAL3 | Mauriporin | 2.63e-03 | 4.38e-02 | NA |
2. P | P01169 | Somatostatin-1 | 1.54e-03 | 2.74e-04 | NA |
2. P | Q9XSV9 | Interleukin-13 | 7.39e-02 | 9.60e-03 | NA |
2. P | D9U2B1 | Neurotoxin beta-KTx 12 | 2.30e-02 | 3.02e-02 | NA |
2. P | P86547 | Osteocalcin-2 | 2.45e-03 | 2.25e-08 | NA |
2. P | O16137 | Defensin-2 | 7.34e-02 | 2.61e-02 | NA |
2. P | D2Y2L2 | U4-theraphotoxin-Hhn1a | 2.52e-03 | 1.66e-02 | NA |
2. P | A0A2Y9GHM8 | Apolipoprotein C-II | 2.39e-03 | 1.76e-03 | NA |
2. P | Q9BP51 | Conotoxin Ar5.1 b | 7.41e-03 | 1.75e-02 | NA |
2. P | P0DUP4 | Apolipoprotein C-II | 6.66e-04 | 1.07e-05 | NA |
2. P | P08947 | [Phe8]-phyllolitorin | 1.58e-02 | 1.98e-04 | NA |
2. P | P49188 | Corticoliberin | 7.08e-04 | 2.47e-02 | NA |
2. P | C0HKT3 | Diuretic hormone class 2 | 1.03e-04 | 1.25e-11 | NA |
2. P | A0A348G5V8 | U-poneritoxin(01)-Om2a | 4.63e-03 | 2.11e-04 | NA |
2. P | P0DP84 | Apolipoprotein A-II | 1.29e-03 | 9.36e-03 | NA |
2. P | P05016 | Interleukin-2 | 4.60e-03 | 4.91e-03 | NA |
2. P | Q800R9 | Caerin 1.11 | 2.01e-03 | 4.00e-03 | NA |
2. P | D0NZB7 | RxLR effector protein PITG_18683 | 6.68e-02 | 1.66e-05 | NA |
2. P | P37997 | Interleukin-2 | 2.04e-02 | 2.93e-03 | NA |
2. P | P0CE38 | Apolipoprotein C-I, basic form | 1.93e-02 | 3.79e-03 | NA |
2. P | B5A9T0 | Dybowskin-2CDYb | 4.88e-02 | 3.63e-03 | NA |
2. P | P57774 | Pro-neuropeptide Y | 2.53e-02 | 7.75e-04 | NA |
2. P | D2Y2N6 | U3-theraphotoxin-Hhn1h | 2.49e-01 | 5.44e-03 | NA |
2. P | Q8MJ39 | Matrix Gla protein | 1.57e-02 | 2.47e-06 | NA |
2. P | M4C319 | RxLR effector protein 62 | 2.44e-03 | 4.17e-02 | NA |
2. P | P28312 | Alpha-defensin 5 | 2.77e-01 | 5.68e-03 | NA |
2. P | P0CI42 | Neurotoxin beta-KTx 14.3 | 1.04e-01 | 4.82e-02 | NA |
2. P | P0DUE8 | Apolipoprotein C-I | 8.00e-03 | 4.51e-03 | NA |
2. P | P01161 | Natriuretic peptides A | 7.70e-03 | 5.81e-04 | NA |
2. P | P51925 | Progonadoliberin-2 | 2.19e-02 | 1.03e-05 | NA |
2. P | Q2V2Q0 | Putative uncharacterized protein YDL007C-A | 3.70e-04 | 1.75e-03 | NA |
2. P | P41520 | Cholecystokinin | 1.33e-02 | 8.00e-05 | NA |
2. P | P0DTR2 | Apolipoprotein A-II | 1.61e-02 | 4.00e-03 | NA |
2. P | P56828 | Interferon tau-1 | 2.23e-02 | 1.47e-02 | NA |
2. P | P01148 | Progonadoliberin-1 | 4.17e-03 | 1.23e-05 | NA |
2. P | Q8JHB9 | Cholecystokinin-8 | 2.30e-02 | 6.30e-05 | NA |
2. P | P86186 | Raniseptin-4 | 5.41e-05 | 4.95e-03 | NA |
2. P | B8K1V9 | Natriuretic peptide Mf-NP | 2.85e-01 | 3.73e-02 | NA |
2. P | P35318 | Pro-adrenomedullin | 3.66e-02 | 2.19e-03 | NA |
2. P | P25308 | Corticoliberin-2 | 5.76e-03 | 5.17e-03 | NA |
2. P | P49794 | Pro-MCH | 1.91e-01 | 3.11e-03 | NA |
2. P | P84223 | Cecropin-C | 7.00e-03 | 5.88e-03 | NA |
2. P | P85411 | Keratinocyte differentiation-associated protein | 1.17e-02 | 1.02e-04 | NA |
2. P | P11052 | Granulocyte-macrophage colony-stimulating factor | 3.12e-02 | 2.16e-03 | NA |
2. P | E2A6Z3 | Allatostatin C | 2.91e-03 | 6.71e-04 | NA |
2. P | C6ZH27 | Neurotoxin beta-KTx 17 | 2.32e-02 | 3.05e-02 | NA |
2. P | O46541 | Natriuretic peptides B | 4.52e-03 | 5.12e-10 | NA |
2. P | C7G3K3 | Beta-KTx-like peptide LaIT2 | 2.83e-02 | 2.25e-02 | NA |
2. P | P0CE37 | Apolipoprotein C-I, acidic form | 3.05e-03 | 6.77e-04 | NA |
2. P | P43443 | Neuromedin-B | 8.72e-03 | 4.28e-03 | NA |
2. P | P18145 | C-type natriuretic peptide | 8.40e-03 | 2.21e-05 | NA |
2. P | Q810H5 | Galanin-like peptide | 6.66e-02 | 2.45e-02 | NA |
2. P | Q99LS0 | Augurin | 2.08e-02 | 1.49e-03 | NA |
2. P | P27104 | Natriuretic peptides A | 1.95e-02 | 2.97e-06 | NA |
2. P | P50724 | Cecropin-A | 8.07e-03 | 2.35e-03 | NA |
2. P | P34405 | FMRFamide-like neuropeptide 23 | 5.53e-02 | 1.36e-03 | NA |
2. P | I7C2V3 | Spexin prohormone 1 | 4.78e-04 | 1.94e-04 | NA |
2. P | A0A5P9K470 | Dermaseptin-SP2 | 7.76e-04 | 4.63e-02 | NA |
2. P | P0DTG5 | Apolipoprotein C-I | 1.51e-03 | 9.44e-03 | NA |
2. P | I3LGZ3 | Protein GPR15L | 5.22e-02 | 4.38e-02 | NA |
2. P | O93464 | Cholecystokinin | 2.06e-02 | 2.81e-07 | NA |
2. P | P0DOC4 | Apolipoprotein C-IV | 1.19e-03 | 1.76e-03 | NA |
2. P | P83056 | Kininogen-1 | 8.53e-03 | 4.10e-03 | NA |
2. P | P07490 | Progonadoliberin-1 | 6.15e-03 | 5.04e-03 | NA |
2. P | A4PIZ9 | Interferon gamma | 2.74e-02 | 2.88e-03 | NA |
2. P | A0A193H365 | Cruzioseptin-7 | 3.79e-05 | 3.93e-03 | NA |
2. P | P01170 | Somatostatin-2 | 1.18e-02 | 4.97e-08 | NA |
2. P | P10334 | Accessory gland-specific peptide 26Ab | 3.05e-02 | 2.99e-05 | NA |
2. P | P0DKY3 | Apolipoprotein C-IV | 3.93e-04 | 4.45e-05 | NA |
2. P | D6C4J8 | Conotoxin Cl14.9 | 9.05e-01 | 4.66e-03 | NA |
2. P | Q9QXK8 | Neuromedin-U | 3.93e-02 | 3.79e-03 | NA |
2. P | P01507 | Cecropin-A | 2.28e-04 | 2.57e-02 | NA |
2. P | D2Y274 | U11-theraphotoxin-Hhn1e | 1.21e-02 | 1.14e-02 | NA |
2. P | P81685 | Cecropin-A1 | 6.54e-03 | 1.12e-02 | NA |
2. P | P18104 | C-type natriuretic peptide | 3.50e-03 | 9.93e-03 | NA |
2. P | A0A286SC82 | RxLR effector protein BLR31 | 1.39e-02 | 3.36e-02 | NA |
2. P | Q6BEG7 | Appetite-regulating hormone | 1.07e-02 | 6.19e-04 | NA |
2. P | A3EX95 | Non-structural protein 3a | NA | 1.62e-04 | NA |
2. P | D2Y2L0 | U4-theraphotoxin-Hhn1a | 1.93e-02 | 7.52e-03 | NA |
2. P | B6DD59 | Toxin-like structure LSTX-R1 | 9.22e-02 | 9.13e-03 | NA |
2. P | P81829 | Leucokinin | 8.87e-03 | 3.85e-05 | NA |
2. P | P05125 | Natriuretic peptides A | 1.93e-02 | 2.47e-04 | NA |
2. P | Q9QXX2 | Interferon gamma | 2.25e-02 | 6.18e-03 | NA |
2. P | D2Y205 | U4-theraphotoxin-Hhn1a | 1.17e-02 | 3.22e-02 | NA |
2. P | P40756 | C-type natriuretic peptide 2 | 3.37e-03 | 8.80e-05 | NA |
2. P | P91758 | Cysteine-rich neurotrophic factor | 7.23e-03 | 9.20e-03 | NA |
2. P | O77763 | Interferon gamma | 1.16e-02 | 1.10e-03 | NA |
2. P | Q28358 | Guanylate cyclase activator 2B | 2.32e-02 | 5.30e-05 | NA |
2. P | P0DN51 | Teretoxin Tan6.1 | 2.79e-01 | 5.17e-03 | NA |
2. P | Q64365 | Neutrophil cationic peptide 1 type B | 3.04e-01 | 1.33e-02 | NA |
2. P | P19939 | Apolipoprotein C-I | 3.48e-03 | 1.00e-02 | NA |
2. P | P80344 | Cholecystokinin | 1.24e-02 | 3.94e-02 | NA |
2. P | P49921 | Progonadoliberin-1 | 4.57e-03 | 4.26e-04 | NA |
2. P | P0CE39 | Apolipoprotein C-I, acidic form | 1.07e-03 | 1.10e-04 | NA |
2. P | Q8AXR3 | C-type natriuretic peptide 1 | 1.41e-02 | 4.11e-08 | NA |
2. P | Q9GLK4 | Natriuretic peptides B | 1.44e-03 | 1.22e-08 | NA |
2. P | P0DTR9 | Apolipoprotein C-II | 5.28e-03 | 1.78e-03 | NA |
2. P | D2Y2K0 | U4-theraphotoxin-Hhn1q | 3.24e-03 | 2.17e-03 | NA |
2. P | D2Y2P0 | Hainantoxin-XVIII-6 | 5.97e-01 | 7.84e-03 | NA |
2. P | E2AJ76 | Short neuropeptide F | 2.13e-03 | 1.66e-05 | NA |
2. P | O93226 | Dermaseptin-A5 | 2.40e-03 | 5.97e-04 | NA |
2. P | P0DSN9 | Serum amyloid A-4 protein | 9.42e-03 | 9.60e-03 | NA |
2. P | P02656 | Apolipoprotein C-III | 7.78e-03 | 5.15e-06 | NA |
2. P | Q9MZ28 | Sperm-associated antigen 11 | 1.84e-01 | 1.82e-02 | NA |
2. P | B3IUE0 | Diuretic hormone 45 | 2.03e-03 | 9.67e-05 | NA |
2. P | Q86C51 | U5-theraphotoxin-Hs1a 1 | 7.50e-02 | 3.61e-02 | NA |
2. P | P0DUP3 | Apolipoprotein C-II | 7.51e-04 | 8.96e-06 | NA |
2. P | P0CF78 | Apolipoprotein C-I, acidic form | 1.54e-03 | 8.32e-03 | NA |
2. P | P0DPY3 | U-scoloptoxin(10)-Er1a | 6.49e-03 | 2.68e-03 | NA |
2. P | Q8MKF5 | Interferon gamma | 1.10e-02 | 3.15e-02 | NA |
2. P | Q9EQX0 | Appetite-regulating hormone | 5.31e-03 | 2.37e-05 | NA |
2. P | P84222 | Cecropin-C | 1.43e-02 | 5.88e-03 | NA |
2. P | P30933 | Seminal vesicle secretory protein 5 | 4.00e-02 | 1.07e-02 | NA |
2. P | P0DKW4 | Apolipoprotein C-IV | 1.23e-03 | 5.26e-03 | NA |
2. P | Q765I0 | Urotensin-2B | 5.18e-04 | 6.40e-09 | NA |
2. P | Q800Y1 | Osteocalcin | 2.24e-02 | 1.05e-02 | NA |
2. P | P0DN50 | Teretoxin Tsu6.16 | 8.35e-02 | 3.61e-02 | NA |
2. P | B6HY14 | Caerin-regulated peptide | 4.34e-04 | 6.13e-03 | NA |
2. P | Q9BPD9 | Conotoxin TsMLCL-04 | 1.38e-03 | 9.70e-06 | NA |
2. P | P02822 | Osteocalcin | 6.67e-03 | 3.46e-06 | NA |
2. P | P50704 | Alpha-defensin 6/12 | 1.25e-01 | 1.34e-03 | NA |
2. P | A0A0A7DNP6 | Prepro-gonadotropin-releasing hormone-like protein | 1.19e-03 | 2.71e-06 | NA |
2. P | Q2I2P1 | Contulakin-Lt1 | 9.70e-02 | 1.01e-05 | NA |
2. P | P07712 | Abdominal ganglion neuropeptides L5-67 | 7.98e-02 | 2.37e-06 | NA |
2. P | Q9UBU3 | Appetite-regulating hormone | 1.55e-02 | 4.82e-02 | NA |
2. P | P10601 | Pancreatic prohormone | 6.70e-03 | 2.09e-04 | NA |
2. P | P84348 | Osteocalcin | 1.04e-01 | 4.34e-02 | NA |
2. P | B1P1A7 | U3-theraphotoxin-Cg1b | 2.04e-02 | 4.59e-02 | NA |
2. P | P07198 | Xenopsin peptides | 9.81e-03 | 1.22e-06 | NA |
2. P | Q28809 | Interleukin-3 | 8.81e-02 | 1.66e-04 | NA |
2. P | D2Y243 | U3-theraphotoxin-Hhn1a 4 | 1.09e-01 | 2.39e-02 | NA |
2. P | P18657 | Apolipoprotein C-I, basic form | 3.94e-03 | 1.10e-05 | NA |
2. P | P70107 | Guanylate cyclase activator 2B | 5.42e-02 | 1.64e-04 | NA |
2. P | P08700 | Interleukin-3 | 7.25e-02 | 1.41e-04 | NA |
2. P | P83962 | Ventricular natriuretic peptide | 1.13e-02 | 6.18e-05 | NA |
2. P | P33622 | Apolipoprotein C-III | 2.23e-03 | 5.91e-04 | NA |
2. P | D2Y229 | U4-theraphotoxin-Hhn1a | 8.95e-04 | 2.27e-02 | NA |
2. P | P0DN99 | Precursor of CEP12 | 1.75e-02 | 3.28e-02 | NA |
2. P | P81688 | Cecropin-A1 | 1.48e-02 | 3.28e-02 | NA |
2. P | P0DUP6 | Apolipoprotein C-IV | 8.63e-04 | 5.16e-04 | NA |
2. P | P0CV51 | Secreted RxLR effector protein 123 | 5.20e-03 | 3.79e-02 | NA |
2. P | P01146 | UI | 1.19e-02 | 1.11e-04 | NA |
2. P | P0DKU8 | Apolipoprotein C-I, basic form | 3.44e-03 | 3.03e-04 | NA |
2. P | A0MLS4 | Appetite-regulating hormone | 1.62e-02 | 3.33e-03 | NA |
2. P | P0DPG1 | Apolipoprotein C-I, basic form | 1.18e-03 | 1.10e-05 | NA |
2. P | P0DPH5 | Apolipoprotein C-I | 1.01e-02 | 1.32e-02 | NA |
2. P | P18656 | Apolipoprotein A-II | 1.29e-02 | 4.32e-03 | NA |
2. P | P48645 | Neuromedin-U | 1.44e-02 | 2.60e-06 | NA |
2. P | O95399 | Urotensin-2 | 1.16e-02 | 2.12e-07 | NA |
2. P | P0CV20 | Secreted RxLR effector protein 69 | 2.68e-02 | 2.50e-03 | NA |
2. P | Q86PR5 | Cecropin-B1 | 7.85e-03 | 2.33e-02 | NA |
2. P | Q95336 | Progonadoliberin-2 | 5.76e-02 | 2.59e-04 | NA |
2. P | O80460 | Precursor of CEP3 | 8.00e-02 | 1.45e-04 | NA |
2. P | Q3LHH8 | Exocrine gland-secreted peptide 1 | 7.12e-03 | 1.11e-07 | NA |
2. P | P81872 | Neuromedin-U | 2.83e-02 | 3.08e-03 | NA |
2. P | Q2XXL8 | Natriuretic peptide GNP1 | 1.64e-02 | 1.58e-03 | NA |
2. P | Q8HYC2 | Urotensin-2 | 7.17e-03 | 1.99e-07 | NA |
2. P | Q9PU29 | Cholecystokinin | 1.43e-02 | 1.17e-03 | NA |
2. P | Q9DGC8 | Progonadoliberin-1 | 3.18e-03 | 2.21e-04 | NA |
2. P | Q805D7 | Brain natriuretic peptide | 4.95e-02 | 5.16e-04 | NA |
2. P | P01172 | Somatostatin-2 | 8.06e-02 | 2.72e-02 | NA |
2. P | Q6R7L0 | Uncharacterized protein ORF13 | NA | 6.29e-03 | NA |
2. P | B1P1I4 | U31-theraphotoxin-Cg1b | 6.61e-03 | 3.79e-02 | NA |
2. P | P56283 | C-type natriuretic peptide | 1.61e-03 | 7.27e-03 | NA |
2. P | P83860 | Orexigenic neuropeptide QRFP | 7.85e-02 | 3.60e-03 | NA |
2. P | Q863C3 | Gastrin-releasing peptide | 2.53e-03 | 1.23e-06 | NA |
2. P | P69156 | Pro-MCH 2 | 1.23e-01 | 1.70e-02 | NA |
2. P | Q963A8 | Cecropin-C type 2 | 1.13e-02 | 3.10e-02 | NA |
2. P | P68421 | U1-theraphotoxin-Hs1a | 6.92e-03 | 4.34e-02 | NA |
2. P | D5KXG9 | Turripeptide UID-02 | 3.38e-02 | 1.43e-02 | NA |
2. P | C0HKU2 | Myosuppressin | 1.58e-02 | 3.79e-02 | NA |
2. P | Q6EBC2 | Interleukin-31 | 2.38e-02 | 7.77e-03 | NA |
2. P | Q0IUL4 | Phytosulfokines 2 | 1.96e-02 | 4.86e-02 | NA |
2. P | P60272 | U2-hexatoxin-Hi1a | 1.49e-02 | 3.02e-02 | NA |
2. P | Q08648 | Sperm-associated antigen 11B | 1.53e-01 | 2.95e-03 | NA |
2. P | P80111 | Gastrin/cholecystokinin-like peptide | 1.73e-03 | 7.84e-03 | NA |
2. P | P28341 | Interferon gamma | 6.15e-03 | 5.17e-03 | NA |
2. P | O35497 | Interferon gamma | 2.35e-02 | 1.25e-02 | NA |
2. P | P50713 | Alpha-defensin 15 | 1.85e-01 | 4.55e-03 | NA |
2. P | P27917 | Apolipoprotein C-III | 9.61e-04 | 1.27e-03 | NA |
2. P | P07492 | Gastrin-releasing peptide | 5.28e-04 | 2.15e-04 | NA |
2. P | W2PED7 | RxLR effector protein PPTG_18954 | 1.90e-02 | 2.58e-05 | NA |
2. P | P0DJD2 | Apolipoprotein A-II | 1.72e-02 | 2.83e-02 | NA |
2. P | P0DPH6 | Apolipoprotein C-I | 1.90e-02 | 3.06e-03 | NA |
2. P | D2Y2H1 | Hainantoxin-XVIII-3 | 1.30e-01 | 4.47e-03 | NA |
2. P | P45656 | Progonadoliberin-1 | 5.63e-03 | 1.28e-04 | NA |
2. P | B3P309 | Protein Turandot X | 6.89e-03 | 5.49e-03 | NA |
2. P | P0DP55 | Pro-neuropeptide Y | 1.42e-03 | 4.12e-05 | NA |
2. P | P70074 | Progonadoliberin-1 | 5.61e-02 | 1.11e-08 | NA |
2. P | F4JRC5 | PAMP-induced secreted peptide 2 | 4.16e-02 | 3.16e-06 | NA |
2. P | P47212 | Galanin peptides | 3.00e-02 | 2.01e-09 | NA |
2. P | D2Y2P1 | Hainantoxin-XVIII-7 | 9.01e-01 | 1.31e-02 | NA |
2. P | Q805D6 | C-type natriuretic peptide 1 | 2.93e-03 | 7.87e-07 | NA |
2. P | P79695 | Pro-glucagon | 1.17e-03 | 7.04e-06 | NA |
2. P | P85832 | Orcokinin peptides | 2.31e-02 | 2.97e-06 | NA |
2. P | Q94557 | Cecropin-1/3 | 6.89e-03 | 5.30e-04 | NA |
2. P | A0A172M416 | Secreted RxLR effector protein 9 | 4.10e-03 | 4.40e-08 | NA |
2. P | P28674 | Pro-neuropeptide Y | 1.44e-02 | 5.83e-05 | NA |
2. P | D2Y2M8 | U3-theraphotoxin-Hhn1a 16 | 1.71e-01 | 4.41e-02 | NA |
2. P | Q800I7 | C-type natriuretic peptide 4 | 2.11e-02 | 3.32e-06 | NA |
2. P | Q9GKY5 | Appetite-regulating hormone | 5.26e-02 | 6.93e-05 | NA |
2. P | P34521 | Uncharacterized protein K11H3.5 | 3.60e-04 | 2.73e-03 | NA |
2. P | Q0P5P2 | Uncharacterized protein C17orf67 | 3.69e-03 | 1.52e-02 | NA |
2. P | Q32KM8 | Augurin | 2.75e-02 | 4.31e-02 | NA |
2. P | D2Y2M1 | U3-theraphotoxin-Hhn1a 12 | 1.55e-01 | 4.24e-02 | NA |
2. P | Q3L180 | Alpha-defensin 26 | 3.49e-01 | 5.50e-04 | NA |
2. P | C0HJV6 | Cytoinsectotoxin-4 | 8.76e-03 | 3.47e-02 | NA |
2. P | D2Y210 | U4-theraphotoxin-Hhn1a | 8.15e-03 | 1.13e-02 | NA |
2. P | P0DM26 | Conorfamide-Tx1 | 1.21e-02 | 4.38e-02 | NA |
2. P | Q9QZQ4 | Urotensin-2 | 3.93e-04 | 8.39e-05 | NA |
2. P | Q9BPE0 | Conotoxin Vn5.6 | 6.06e-02 | 6.36e-04 | NA |
2. P | P0DTQ6 | Apolipoprotein C-II | 4.58e-04 | 4.28e-05 | NA |
2. P | D2Y2J2 | U4-theraphotoxin-Hhn1k | 1.07e-02 | 1.30e-02 | NA |
2. P | Q6BEG6 | Appetite-regulating hormone | 5.92e-03 | 6.86e-05 | NA |
2. P | L7VIN3 | Cecropin-like peptide 1 | 3.40e-04 | 3.89e-04 | NA |
2. P | E7EKE1 | Brevinin-2HS2B | 2.95e-04 | 2.90e-03 | NA |
2. P | P0DPH3 | Apolipoprotein C-I | 5.37e-04 | 1.61e-03 | NA |
2. P | Q60549 | Somatoliberin | 1.97e-03 | 5.05e-07 | NA |
2. P | E7EZ53 | Galanin peptides | 8.74e-03 | 8.95e-04 | NA |
2. P | D2Y2J3 | U4-theraphotoxin-Hhn1l | 1.32e-02 | 6.29e-03 | NA |
2. P | D2Y230 | U4-theraphotoxin-Hhn1a | 1.49e-03 | 4.59e-02 | NA |
2. P | Q6QN06 | Matrix Gla protein | 1.68e-02 | 3.70e-03 | NA |
2. P | Q9W6M9 | Galanin peptides | 1.39e-02 | 4.94e-06 | NA |
2. P | P81486 | Dermaseptin-B4 | 4.14e-04 | 1.56e-02 | NA |
2. P | P13083 | Pancreatic prohormone | 3.68e-02 | 4.49e-10 | NA |
2. P | Q868F8 | Allatostatin | 3.89e-02 | 1.22e-03 | NA |
2. P | T1W425 | Apolipoprotein C-II | 1.61e-03 | 1.29e-03 | NA |
2. P | P50720 | Hyphancin-3D | 1.49e-02 | 4.32e-03 | NA |
2. P | P16859 | Natriuretic peptides B | 3.14e-03 | 8.29e-07 | NA |
2. P | P0DMA7 | Apolipoprotein C-I, basic form (Fragment) | 2.94e-05 | 5.68e-03 | NA |
2. P | P30438 | Major allergen I polypeptide chain 1 | 9.22e-02 | 3.38e-02 | NA |
2. P | P33739 | Accessory gland-specific peptide 26Ab | 1.18e-01 | 7.55e-06 | NA |
2. P | D2Y247 | U3-theraphotoxin-Hhn1m | 1.46e-01 | 2.03e-02 | NA |
2. P | O09051 | Guanylate cyclase activator 2B | 8.37e-03 | 1.69e-05 | NA |
2. P | P52880 | Uncharacterized protein F46C5.1 | 5.30e-04 | 3.17e-10 | NA |
2. P | Q7Q7R8 | Neuropeptide F | 8.41e-03 | 1.05e-04 | NA |
2. P | P55206 | C-type natriuretic peptide | 3.49e-03 | 3.50e-02 | NA |
2. P | Q9LMY9 | Phytosulfokines 1 | 6.61e-03 | 8.25e-03 | NA |
2. P | P0CU94 | Secreted RxLR effector protein 7 | 1.70e-03 | 1.61e-04 | NA |
2. P | P01298 | Pancreatic prohormone | 4.76e-03 | 5.89e-05 | NA |
2. P | A0A125S9D9 | Conotoxin Im22.1 | 4.02e-01 | 5.68e-03 | NA |
2. P | D2Y212 | U4-theraphotoxin-Hhn1a | 1.74e-03 | 4.74e-03 | NA |
2. P | Q94990 | Cecropin-2 | 8.08e-06 | 8.95e-04 | NA |
2. P | P50723 | Hyphancin-3G | 8.45e-03 | 2.04e-02 | NA |
2. P | Q9DGC9 | Progonadoliberin-2 | 1.42e-02 | 8.19e-06 | NA |
2. P | A0A193H362 | Cruzioseptin-2 | 1.09e-03 | 2.88e-02 | NA |
2. P | Q1ELT9 | M-zodatoxin-Lt1a | 3.47e-02 | 1.43e-02 | NA |
2. P | Q865W6 | Interferon gamma | 5.57e-03 | 4.62e-04 | NA |
2. P | P0CAX4 | Augurin-B | 1.28e-02 | 7.41e-04 | NA |
2. P | Q805D4 | C-type natriuretic peptide 3 | 6.54e-03 | 1.79e-02 | NA |
2. P | P0DTR7 | Apolipoprotein C-I, basic form | 6.00e-04 | 1.10e-05 | NA |
2. P | P34929 | Apolipoprotein C-I, basic form | 3.20e-03 | 3.67e-05 | NA |
2. P | M0R8L2 | Spexin | 4.54e-03 | 8.63e-05 | NA |
2. P | P0DSK2 | M-poneratoxin-Dq4e | 2.75e-03 | 2.25e-02 | NA |
2. P | Q9QZQ3 | Urotensin-2 | 4.83e-04 | 9.31e-05 | NA |
2. P | Q9VET0 | Neuropeptide F | 4.95e-03 | 2.39e-07 | NA |
2. P | A0A096P2H6 | Apolipoprotein C-IV | 4.97e-04 | 3.61e-04 | NA |
2. P | O61272 | Cecropin-A1 | 1.22e-03 | 9.88e-04 | NA |
2. P | Q99MP5 | Promotilin | 6.47e-03 | 1.02e-03 | NA |
2. P | P26917 | Somatostatin | 2.70e-02 | 9.60e-07 | NA |
2. P | Q8LA14 | Putative phytosulfokines 6 | 1.23e-01 | 7.68e-09 | NA |
2. P | P11159 | PBAN-type neuropeptides | 4.45e-02 | 1.79e-03 | NA |
2. P | P01350 | Gastrin | 1.08e-01 | 3.91e-02 | NA |
2. P | P17803 | Interferon gamma | 3.90e-03 | 3.93e-03 | NA |
2. P | Q865Y4 | Interferon gamma | 1.03e-02 | 1.02e-02 | NA |
2. P | Q9FEB4 | Phytosulfokines 5 | 6.20e-03 | 4.70e-08 | NA |
2. P | P28672 | Pro-neuropeptide Y | 4.51e-02 | 3.67e-05 | NA |
2. P | P09929 | Pigment-dispersing hormone peptides | 2.09e-03 | 2.22e-02 | NA |
2. P | Q1HA14 | Neuromedin-S | 1.29e-02 | 3.37e-08 | NA |
2. P | P09683 | Secretin | 2.85e-02 | 3.54e-04 | NA |
2. P | E2E4L2 | Goannatyrotoxin-Vere1 | 8.16e-03 | 2.06e-09 | NA |
2. P | Q5RDP6 | Matrix Gla protein | 6.09e-03 | 1.51e-04 | NA |
2. P | E3P6S4 | Delta-aiptatoxin-Adi1a | 7.63e-03 | 2.90e-02 | NA |
2. P | B5LUQ3 | Preprofallaxidin-2 | 5.84e-03 | 1.98e-02 | NA |
2. P | Q765I1 | Urotensin-2B | 8.09e-04 | 4.86e-05 | NA |
2. P | D3Z752 | Spexin | 1.02e-03 | 1.17e-03 | NA |
2. P | Q8C1P2 | Alpha-defensin 21 | 1.39e-01 | 8.90e-03 | NA |
2. P | Q299E6 | Protein Turandot X | 5.61e-03 | 9.60e-03 | NA |
2. P | A0A2U3Y4D7 | Apolipoprotein C-II | 1.87e-03 | 1.58e-04 | NA |
2. P | C0HK02 | Ocellatin-PT7 | 2.49e-04 | 1.02e-04 | NA |
2. P | P07808 | Pro-neuropeptide Y | 4.08e-03 | 7.89e-04 | NA |
2. P | Q8MIQ5 | Apolipoprotein A-II | 1.15e-02 | 1.11e-03 | NA |
2. P | P07501 | Natriuretic peptides A | 3.65e-02 | 5.86e-08 | NA |
2. P | P48098 | Peptide YY-like | 2.98e-03 | 4.08e-05 | NA |
2. P | P84715 | C-type natriuretic peptide | 2.34e-03 | 1.05e-04 | NA |
2. P | P91964 | Pigment-dispersing hormone type 2 | 2.83e-02 | 1.56e-05 | NA |
2. P | P0DTT4 | Apolipoprotein C-I | 1.78e-03 | 4.62e-04 | NA |
2. P | A0A193H396 | Cruzioseptin-6 | 6.04e-05 | 1.13e-03 | NA |
2. P | Q9XYR5 | Contulakin-G | 7.75e-03 | 1.15e-02 | NA |
2. P | Q805E9 | Natriuretic peptides A | 3.59e-04 | 1.50e-07 | NA |
2. P | Q9PW68 | Pro-neuropeptide Y | 4.05e-03 | 3.33e-07 | NA |
2. P | P33738 | Accessory gland-specific peptide 26Ab | 5.88e-02 | 3.61e-06 | NA |
2. P | Q9BPE1 | Conotoxin Vn5.5 | 8.16e-03 | 4.63e-05 | NA |
2. P | D6C4K2 | Conotoxin Cl6.12 | 2.59e-01 | 8.82e-03 | NA |
2. P | P0CJ45 | Neurotoxin beta-KTx 52.1 | 2.85e-03 | 4.82e-02 | NA |
2. P | P68630 | Uncharacterized 8.9 kDa protein | NA | 4.14e-02 | NA |
2. P | O81483 | Late embryogenesis abundant protein M10 | 2.56e-02 | 4.94e-02 | NA |
2. P | P67791 | Cecropin-B | 1.10e-02 | 1.48e-02 | NA |
2. P | D2Y2M0 | U3-theraphotoxin-Hhn1q | 1.22e-01 | 2.20e-02 | NA |
2. P | P91793 | Defensin-A | 3.64e-02 | 2.63e-02 | NA |
2. P | O48776 | Protein RALF-like 17 | 6.91e-03 | 4.79e-03 | NA |
2. P | O73811 | Progonadoliberin-2 | 1.94e-02 | 1.81e-07 | NA |
2. P | Q8T0Y7 | Neuropeptides CP2 | 9.06e-03 | 1.06e-12 | NA |
2. P | Q76IQ4 | Ghrelin | 2.73e-02 | 2.27e-02 | NA |
2. P | Q9PTA0 | Pro-neuropeptide Y | 7.34e-03 | 3.54e-04 | NA |
2. P | P20726 | Serum amyloid A-1 protein | 9.47e-03 | 4.63e-02 | NA |
2. P | Q805D3 | C-type natriuretic peptide 4 | 1.40e-03 | 1.28e-08 | NA |
2. P | Q9IA10 | Progonadoliberin-1 | 2.19e-02 | 6.40e-08 | NA |
2. P | B2RZ42 | ALK and LTK ligand 2 | 4.67e-03 | 2.75e-03 | NA |
2. P | P60041 | Somatostatin | 2.41e-03 | 1.04e-06 | NA |
2. P | Q8WVF2 | Unique cartilage matrix-associated protein | 3.34e-04 | 2.57e-02 | NA |
2. P | A8WU84 | FMRFamide-like neuropeptides 27 | 4.42e-02 | 7.55e-04 | NA |
2. P | C0HL91 | Adipokinetic prohormone type 1 | 1.14e-02 | 3.36e-02 | NA |
2. P | P24512 | Chorion protein S16 | 3.12e-03 | 1.09e-03 | NA |
2. P | P76001 | Uncharacterized protein YcgJ | 8.85e-01 | 3.58e-02 | NA |
2. P | D2Y221 | U4-theraphotoxin-Hhn1b | 8.04e-03 | 2.04e-02 | NA |
2. P | P69155 | Pro-MCH 2 | 1.67e-01 | 1.70e-02 | NA |
2. P | D2Y2J1 | U4-theraphotoxin-Hhn1j | 9.33e-05 | 3.91e-02 | NA |
2. P | D9U2B5 | Bradykinin-potentiating peptide NDBP6 | 1.00e-02 | 3.76e-02 | NA |
2. P | P11478 | Neutrophil cationic peptide 1 type A | 2.90e-01 | 1.13e-02 | NA |
2. P | A0A0D9S1R9 | Apolipoprotein C-II | 4.12e-03 | 5.53e-03 | NA |
2. P | W4VSB0 | Toxin ICK-24 | 1.70e-02 | 2.20e-02 | NA |
2. P | P50711 | Alpha-defensin 13 | 3.23e-01 | 9.20e-04 | NA |
2. P | P06518 | Abdominal ganglion neuropeptide L11 | 6.16e-03 | 4.81e-05 | NA |
2. P | Q8T112 | Cerebrin prohormone | 6.60e-03 | 6.00e-05 | NA |
2. P | Q95150 | Neurotrophin-3 (Fragment) | 3.47e-02 | 8.23e-05 | NA |
2. P | Q5G864 | Alpha-defensin 25 | 1.47e-01 | 5.81e-04 | NA |
2. P | P04142 | Cecropin-B | 9.95e-03 | 2.61e-02 | NA |
2. P | O93223 | Dermaseptin-A3 | 6.41e-05 | 7.84e-03 | NA |
2. P | D2Y493 | Conotoxin Cal6.3a | 1.97e-01 | 3.67e-03 | NA |
2. P | P42634 | Prosialokinin | 1.17e-02 | 2.64e-03 | NA |
2. P | Q6R799 | Uncharacterized protein ORF120 | NA | 9.97e-04 | NA |
2. P | O54713 | Progonadoliberin-1 | 2.30e-03 | 1.18e-04 | NA |
2. P | B5A9T1 | Dybowskin-2CDYa | 1.52e-01 | 3.05e-02 | NA |
2. P | P42160 | Interferon gamma | 1.24e-02 | 2.14e-03 | NA |
2. P | B3P312 | Protein Turandot B1 | 2.15e-02 | 2.53e-02 | NA |
2. P | P07634 | Natriuretic peptides B | 1.86e-03 | 3.29e-10 | NA |
2. P | O73812 | Progonadoliberin-1 | 5.17e-02 | 2.97e-06 | NA |
2. P | D0NZA8 | RxLR effector protein PITG_18670 | 6.10e-04 | 2.27e-05 | NA |
2. P | Q2WCN8 | Pelophylaxin-1 | 3.90e-04 | 4.21e-02 | NA |
2. P | O81277 | Phytosulfokines 5 | 3.11e-02 | 8.90e-03 | NA |
2. P | Q5H8A3 | Neuromedin-S | 1.92e-02 | 1.98e-10 | NA |
2. P | P0DTG4 | Apolipoprotein C-I | 9.93e-03 | 2.27e-04 | NA |
2. P | Q91194 | Somatostatin-2 | 2.28e-02 | 3.05e-02 | NA |
2. P | P70668 | Guanylate cyclase activator 2B | 5.28e-02 | 3.63e-05 | NA |
2. P | P63311 | Interferon gamma | 1.28e-02 | 1.96e-02 | NA |
2. P | Q7Z4H4 | Protein ADM2 | 1.58e-01 | 1.16e-09 | NA |
2. P | P60985 | Keratinocyte differentiation-associated protein | 3.29e-02 | 6.56e-06 | NA |
2. P | W4VSB6 | Conotoxin Vc7.1 | 4.54e-01 | 1.32e-02 | NA |
2. P | P68631 | Uncharacterized 8.9 kDa protein | NA | 4.14e-02 | NA |
2. P | Q9XSW6 | Pro-neuropeptide Y | 1.72e-02 | 3.95e-06 | NA |
2. P | P0CE40 | Apolipoprotein C-I, basic form | 6.31e-05 | 2.57e-03 | NA |
2. P | W4VRX0 | Toxin ICK-22 | 2.24e-01 | 7.64e-03 | NA |
2. P | Q8UW81 | Progonadoliberin-2 | 1.24e-02 | 1.02e-03 | NA |
2. P | P61110 | Kidney androgen-regulated protein | 2.48e-02 | 1.08e-02 | NA |
2. P | A0A1B0GTC6 | Uncharacterized protein C3orf85 | 1.78e-03 | 5.25e-05 | NA |
2. P | A2ZBG5 | Phytosulfokines 2 | 9.51e-03 | 2.18e-02 | NA |
2. P | P55797 | Apolipoprotein C-IV | 8.29e-04 | 3.11e-03 | NA |
2. P | O16829 | Cecropin-C | 1.14e-02 | 2.83e-03 | NA |
2. P | P86546 | Osteocalcin | 9.36e-03 | 3.51e-07 | NA |
2. P | P0DP51 | Apolipoprotein C-I | 1.24e-02 | 3.28e-03 | NA |
2. P | P86188 | Raniseptin-8 | 2.96e-05 | 3.50e-02 | NA |
2. P | P16043 | Somatoliberin | 4.59e-04 | 4.35e-08 | NA |
2. P | Q64356 | Seminal vesicle secretory protein 6 | 2.08e-02 | 6.41e-04 | NA |
3. B | P31888 | Calcitonin gene-related peptide | 6.69e-04 | NA | 1.67e-16 |
3. B | P12967 | Islet amyloid polypeptide | 4.19e-03 | NA | 2.97e-08 |
3. B | Q28934 | Islet amyloid polypeptide (Fragment) | 3.18e-02 | NA | 0.042 |
3. B | P10997 | Islet amyloid polypeptide | 1.90e-02 | NA | 2.34e-06 |
3. B | P30880 | Calcitonin gene-related peptide | 6.51e-04 | NA | 2.58e-16 |
3. B | P12966 | Islet amyloid polypeptide | 4.28e-03 | NA | 4.65e-06 |
3. B | P12968 | Islet amyloid polypeptide | 1.77e-02 | NA | 1.22e-08 |
3. B | P30881 | Calcitonin gene-related peptide | 7.36e-04 | NA | 1.28e-17 |
3. B | Q07334 | Islet amyloid polypeptide (Fragment) | 4.75e-03 | NA | 0.005 |
3. B | Q28207 | Islet amyloid polypeptide | 1.31e-02 | NA | 4.80e-06 |
3. B | P19890 | Islet amyloid polypeptide | 1.01e-01 | NA | 0.001 |